UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

———————

FORM 10-Q

———————

(Mark One)

ý

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended: DECEMBER 31, 2007

Or

¨

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from ________ to ________

PARLUX FRAGRANCES, INC.

(Exact name of registrant as specified in its charter)

______________

DELAWARE

0-15491

22-2562955

(State or other jurisdiction of
incorporation or organization)

(Commission
file number)

(IRS employer
identification no.)

3725 S.W. 30th Avenue, Ft. Lauderdale, FL 33312

(Address of principal executive offices) (Zip code)

Registrant’s telephone number, including area code 954-316-9008

_______________________________________________________

(Former name, former address and former fiscal year, if changed since last report)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes  ý No  ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, or a non-accelerated filer. See definition of “accelerated filer and large accelerated filer” in Rule 12b-2 of the Exchange Act.

Large accelerated filer ¨   Accelerated filer ý   Non-accelerated filer ¨

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes  ¨ No  ý

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.

Class

Outstanding at February 6, 2008

[Common Stock, $0.01 par value per share]

20,284,912 shares

 

 

 






PART I. – FINANCIAL INFORMATION

UNAUDITED

Item 1.

Financial Statements

See pages 16 to 32.

Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations.

Parlux Fragrances, Inc. is a manufacturer and international distributor of prestige products. We hold licenses for Paris Hilton fragrances, watches, cosmetics, sunglasses, handbags and other small leather accessories in addition to licenses to manufacture and distribute the designer fragrance brands of GUESS?, Jessica Simpson, Nicole Miller, XOXO, Ocean Pacific (OP), Maria Sharapova, Andy Roddick, babyGund, and Fred Hayman Beverly Hills.

Certain statements within this Quarterly Report on Form 10-Q, which are not historical in nature, including those that contain the words, “anticipate”; “believe”; “plan”; “estimate”; “expect”; “should”; “intend”; and other similar expressions, are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. All forward-looking statements are based on current expectations. Investors are cautioned that forward-looking statements involve many risks and uncertainties, which may affect our business and prospects, including economic, competitive, governmental and other factors included in our filings with the Securities and Exchange Commission, including the Risk Factors included in our Annual Report on Form 10-K, for the year ended March 31, 2007. Accordingly, actual results may differ materially from those expressed in the forward-looking statements, and the making of such statements should not be regarded as a representation by the Company or any other person that the results expressed in the statements will be achieved. We do not undertake any obligation to update the forward-looking information herein, which speaks only as of this date.

On May 17, 2006, we announced a two-for-one stock split of common stock in the form of a dividend, for stockholders of record on May 31, 2006 (the “Stock Split”). The Stock Split was effected on June 16, 2006 and did not include shares held in treasury. In connection with the Stock Split, we modified outstanding warrants. See Note B to the accompanying condensed consolidated financial statements for further discussion of the effect of the modification of warrants in connection with the Stock Split and the related non-cash share-based compensation expense recorded during the nine months ended December 31, 2006.

Recent Developments

Office Lease

On November 30, 2007, we entered into a lease agreement, commencing during February 2008, for 19,072 square feet of office space in Fort Lauderdale, Florida, which will serve as our new corporate headquarters.  We anticipate moving during the second week in February 2008 from our present 99,000 square foot office/warehouse facility, which is currently being marketed for sublease.  Warehouse operations have been consolidated into our 198,050 square foot distribution center in New Jersey.

Jessica Simpson Fragrance License

On June 21, 2007, we entered into an exclusive license agreement with VCJS, LLC, to develop, manufacture and distribute prestige fragrances and related products under the Jessica Simpson name. The initial term of the agreement expires five years from the date of the first product sales and is renewable for an additional five years if certain sales levels are met. We must pay a minimum royalty, whether or not any product sales are made, and spend minimum amounts for advertising based upon sales volume. We anticipate that the first fragrance under this agreement will be launched during late summer 2008.

Nicole Miller Fragrance License

On August 1, 2007, we entered into an exclusive license agreement with Kobra International, Ltd., to develop, manufacture and distribute prestige fragrances and related products under the Nicole Miller name. The initial term of the agreement expires on September 30, 2013 and is renewable for two additional terms of three years each, if certain sales levels are met. We must pay a minimum royalty, whether or not any product sales are made, and spend minimum amounts for advertising based upon sales volume. We anticipate launching a new fragrance



1





under this license in the fall of 2008, and have recently resumed the manufacturing of certain previously developed Nicole Miller fragrances.

Critical Accounting Policies and Estimates

In the ordinary course of business, we have made a number of estimates and assumptions relating to the reporting of results of operations and financial condition in the preparation of our financial statements in conformity with accounting principles generally accepted in the United States of America. Actual results could differ significantly from those estimates under different assumptions and conditions. We have included in our Annual Report on Form 10-K for the year ended March 31, 2007 a discussion of our most critical accounting policies, which are those that are most important to the portrayal of our financial condition and results of operations and require management’s most difficult, subjective and complex judgments, often as a result of the need to make estimates about the effect of matters that are inherently uncertain. We have not made any changes in these critical accounting policies, nor have we made any material change in any of the critical accounting estimates underlying these accounting policies, since the Form 10-K filing, discussed above, except for the adoption of Financial Accounting Standards Board (“FASB”) Interpretation 48 (“FIN 48”) Accounting for Income Tax Uncertainties , discussed below.

On April 1, 2007, we adopted the provisions of FIN 48, which clarifies the accounting for uncertainty in income taxes recognized in the financial statements in accordance with FASB Statement of Financial Accounting Standards No. 109 Accounting for Income Taxes . FIN 48 prescribes a recognition threshold of more-likely-than-not and a measurement attribute on all tax positions taken or expected to be taken in a tax return in order to be recognized in the financial statements. In making this assessment, a company must determine whether it is more-likely-than-not that a tax position will be sustained upon examination, including resolution of any related appeals or litigation processes, based solely on the technical merits of the position and must assume that the tax position will be examined by appropriate taxing authority that would have full knowledge of all relevant information. Once the recognition threshold is met, the tax position is then measured to determine the actual amount of benefit to recognize in the financial statements. In addition, the recognition threshold of more-likely-than-not must continue to be met in each reporting period to support continued recognition of the tax benefit. Tax positions that previously failed to meet the more-likely-than-not recognition threshold should be recognized in the first financial reporting period in which that threshold is met. Previously recognized tax positions that no longer meet the more-likely-than-not recognition threshold should be derecognized in the financial reporting period in which that threshold is no longer met. As a result of the implementation of FIN 48, we did not recognize a liability for unrecognized tax benefits or adjust any recorded liabilities for uncertain tax positions and, accordingly, we were not required to record any cumulative effect adjustment to beginning of year retained earnings. As of both the date of adoption and December 31, 2007, there was no material liability for income tax associated with unrecognized tax benefits. We do not anticipate any material adjustments relating to unrecognized tax benefits within the next twelve months, however, the outcome of tax matters is uncertain and unforeseen results can occur.

New Accounting Pronouncements

In September 2006, the FASB issued Statement of Financial Accounting Standards (“SFAS”) No. 157, Fair Value Measurements (“SFAS No. 157”). SFAS No. 157 defines fair value, establishes a framework for measuring fair value and enhances disclosures about fair value measures required under other accounting pronouncements, but does not change existing guidance as to whether or not an instrument is carried at fair value. SFAS No. 157 is effective for fiscal years beginning after November 15, 2007. We are currently reviewing the provisions of SFAS No. 157 to determine the impact, if any, on our condensed consolidated financial statements.

In February 2007, the FASB issued SFAS No. 159, The Fair Value Option for Financial Assets and Financial Liabilities - Including an Amendment of FASB No. 115 ("SFAS No. 159"). SFAS No. 159 permits companies to choose to measure many financial instruments and certain other items at fair value in order to mitigate volatility in reported earnings caused by measuring related assets and liabilities differently without having to apply complex hedge accounting provisions. SFAS No. 159 is effective for our fiscal year ending March 31, 2009. We are currently assessing the impact, if any, of this statement on our condensed consolidated financial statements.

In December 2007, the FASB issued SFAS No. 141(R), Business Combinations , or (“SFAS 141(R)”). SFAS 141(R) establishes principles and requirements for how the acquirer of a business recognizes and measures in its financial statements the identifiable assets acquired, the liabilities assumed, and any noncontrolling interest in the acquiree. SFAS 141(R) also provides guidance for recognizing and measuring the goodwill acquired in the business combination and determines what information to disclose to enable users of the financial statements to evaluate the



2





nature and financial effects of the business combination. The provisions of SFAS 141(R) are effective for financial statements issued for fiscal years beginning after December 15, 2008. We are currently assessing the financial impact of SFAS 141(R) on our consolidated financial statements.

In December 2007, the FASB issued SFAS 160, Noncontrolling Interests in Consolidated Financial Statements — An Amendment of ARB No. 51 (“SFAS 160”). SFAS 160 amends Accounting Research Bulletin No. 51, “Consolidated Financial Statements,” or ARB 51, to establish accounting and reporting standards for the noncontrolling interest in a subsidiary and for the deconsolidation of a subsidiary. This statement also amends certain of ARB 51’s consolidation procedures for consistency with the requirements of SFAS 141(R). In addition, SFAS 160 also includes expanded disclosure requirements regarding the interests of the parent and its noncontrolling interest. The provisions of SFAS 160 are effective for fiscal years beginning after December 15, 2008. Earlier adoption is prohibited. We are currently assessing the financial impact of SFAS 160 on our consolidated financial statements.

Significant Trends

Over the last few years, a significant number of new prestige fragrance products have been introduced on a worldwide basis. The beauty industry in general is highly competitive and consumer preferences often change rapidly. The initial appeal of these new fragrances, launched for the most part in U.S. department stores, has fueled the growth of our industry. Department stores continue to lose sales to the mass market as a product matures. To counter the effect of lower department store sales, fragrance companies introduce new products more quickly, which requires additional spending for development and advertising and promotional expenses. In addition, a number of the new launches are with celebrities (either entertainers or athletes) which require substantial royalty commitments and whose careers and/or appeal could change drastically, both positively and negatively, based on a single event. We believe these trends will continue. If one or more of our new product introductions would be unsuccessful, or if the appeal of the celebrity would diminish, it could result in a substantial reduction in profitability and operating cash flows.

We cannot accurately predict what affect, if any, the current economic instability will have on future results. In addition, certain U.S. department store retailers have consolidated operations resulting in the closing of retail stores as well as implementing various inventory control initiatives. We expect that these store closings and the inventory control initiatives will continue to negatively affect our sales in the short term.

Results of Operations

As more fully discussed in Note O to the condensed consolidated financial statements, on December 6, 2006, we sold our Perry Ellis fragrance brand license back to Perry Ellis International (“PEI”) at a price of approximately $63 million, including approximately $21 million for inventory and promotional products relating to the brand. Beginning with our third quarter ended December 31, 2006, the Perry Ellis brand activity has been presented as discontinued operations. Prior period statements of operations have been retrospectively adjusted. The discussion on results of operations that follow are based upon the results from continuing operations and exclude any discussion of discontinued operations, unless specifically noted.

We do business with fragrance distributors owned/operated by individuals related to our former Chairman and CEO. Through June 30, 2007, these sales were included as related party sales in the accompanying condensed consolidated statements of operations.  As of June 30, 2007, the former Chairman and CEO’s beneficial ownership interest in the Company was approximately 7.6%.  During the quarter ended September 30, 2007 his beneficial ownership declined to less than 5%.  Accordingly, the Company’s management determined that, effective as of July 1, 2007, transactions with such parties will no longer be reported as related party transactions.  As of December 31, 2007, the former Chairman and CEO’s beneficial ownership interest in the Company was less than 2%.

Our gross margins may not be comparable to other entities that include all of the costs related to their distribution network in costs of goods sold, since we allocate a portion of these distribution costs to costs of goods sold and include the remaining unallocated amounts as selling and distribution expenses. Selling and distribution expenses for the nine months ended December 31, 2007 and 2006 include approximately $3,279,000 and $4,417,000 respectively ($1,511,000 and $2,182,000 for the three months ended December 31, 2007 and 2006), relating to the cost of warehouse operations not allocated to inventories and other related distribution expenses (excluding shipping



3





expenses which are recorded as cost of goods sold). A portion of these costs is allocated to inventory in accordance with generally accepted accounting principles.

In addition, our sales tend to fluctuate with the seasons, as we experience increased sales during holiday gift giving periods assuming stable economic conditions.

Comparison of the three-month period ended December 31, 2007 with the three-month period ended December 31, 2006

Net Sales

During the three months ended December 31, 2007, net sales from continuing operations increased 3% to $44,543,788 as compared to $43,416,309 for the same period in the prior year. The increase is mainly attributable to an increase of $4,110,706 in gross sales of Paris Hilton brand fragrances, which included the recent launch of the new Can Can fragrance which began shipping in September 2007 and generated $4,270,310 in gross sales during the period. Gross sales of Paris Hilton accessories increased by $1,646,949 over the same period in the prior year, as watch sales increased by $1,992,377, but was partially offset by a $345,428 decrease in handbag sales.  Gross sales of GUESS? fragrances decreased $5,291,874 due to restrictions placed upon us by GUESS?, Inc. These restrictions are more fully discussed in Note J to our condensed consolidated financial statements.

Net sales to unrelated customers, which represented 79% of our total net sales for the three months ended December 31, 2007, increased by 18% to $35,055,318 as compared to $29,738,731 for the same period in the prior year, mainly as a result of the Paris Hilton brand sales discussed above. In addition,  effective as of July 1, 2007, sales to certain distributors, that were previously reported as related parties, are now included as unrelated international customer sales. Net sales to the U.S. department store sector decreased 15% to $13,288,524 for the three months ended December 31, 2007 as compared to $15,597,979 for the same period in the prior year, while net sales to unrelated international distributors increased 54% to $21,766,868 from $14,140,754 in the same period of the prior year. The increase in international net sales was primarily a result of growth in the Paris Hilton brand fragrances and accessories. Sales to related parties (See Note F to the condensed consolidated financial statements for further discussion of related parties) decreased 31% to $9,488,470 for the three months ended December 31, 2007, compared to $13,677,578 for the same period in the prior year, mainly as a result of certain international distributers formerly reported as related parties who are no longer considered as such. As sales to these parties have decreased, our sales to Perfumania, Inc. (“Perfumania”) have increased. We anticipate that this trend will continue as sales to Perfumania increase as a result of increased access to its distribution channels. As discussed above, effective July 1, 2007, related party sales include only sales to Perfumania, as sales to certain distributors, that were previously reported as related parties, are now included as unrelated international customer sales.

Cost of Goods Sold

Our overall cost of goods sold decreased as a percentage of net sales to 50% for the three months ended December 31, 2007, compared to 58% for the comparable prior year period. Cost of goods sold as a percentage of net sales to unrelated customers and related parties approximated 49% and 53%, respectively, for the current year period, as compared to 61% and 53%, respectively, for the same period in the prior year.  The prior year period included a higher percentage of value sets sold to unrelated customers, which sets include multiple products and have a higher cost of goods compared to basic stock items.  The prior year period also included a higher percentage of sales of GUESS? products which sales, for the most part, have a lower margin than sales of our other products.

Total Operating Expenses

Total operating expenses decreased by 17% compared to the same period in the prior year to $21,896,502, from $26,312,768, decreasing as a percentage of net sales from 61% to 49%. The decrease is mainly attributable to lower advertising and promotional expenses.  An analysis of individual components of our operating expenses is discussed below.

Advertising and Promotional Expenses

Advertising and promotional expenses decreased 22% to $12,454,247, compared to $16,018,065 in the comparable prior year period, decreasing as a percentage of net sales from 37% to 28%. The current period reflects a targeted effort on the part of management to control these expenses in the current year.  During the current year period, we commenced a significant advertising campaign for the Paris Hilton fragrance brands in conjunction with



4





the launch of Paris Hilton Can Can. During the prior year period we incurred promotional costs in connection with the continued roll out of Paris Hilton and GUESS? fragrances for women and men on a worldwide basis and GUESS GOLD women’s fragrance and Paris Hilton “Heiress” for women fragrance, mainly in U.S. department stores.

Selling and Distribution Costs

Selling and distribution costs decreased 13% to $3,358,058 compared to $3,874,413 in the comparable prior year period, decreasing as a percentage of net sales from 9% to 8%. The decrease was mainly attributable to the centralization of all distribution activities in our New Jersey facility, resulting in a decrease of staff in our Florida warehouse facility. The prior year period also included approximately $ 355,000 for inventory relocation costs in connection with our shifting of distribution activities to New Jersey.

Royalties

Royalties increased by 13% in the current period, to $3,301,514 from $2,918,811 in the corresponding prior year period, remaining relatively constant as a percentage of net sales at 7%. This rate, in comparison to actual rates under our various license agreements, is higher due to provisions for minimum royalties related to licensed accessory products (primarily our sunglass and cosmetics licenses, which have no sales).

General and Administrative Expenses

General and administrative expenses decreased 30% compared to the prior year period, from $2,833,276 to $1,975,670, and decreased as a percentage of sales to 4% from 7% in the prior year period. The decrease is due to a targeted effort on the part of management to reduce overall expenses while increasing accounting and financial resources in order to address and remediate the material weaknesses reported in our Annual Report on Form 10-K for the year ended March 31, 2007.  The prior year period also included approximately $547,000 of additional legal expenses than the current year period, as various litigation was resolved during fiscal 2007.

Depreciation and Amortization

Depreciation and amortization increased 21% in the current year period from $668,203 to $807,013 but remained constant as a percentage of sales at 2%. The increased expense reflects a $200,000 impairment charge for the XOXO fragrance license during the current period.

Operating Income (Loss)

As a result of the aforementioned factors, we generated operating income from continuing operations of $ 493,840 for the current period, compared to an operating loss from continuing operations of $8,218,192 for the comparable period in the prior year.

Net interest expense

Net interest expense (including bank charges, and net of interest income) decreased 63% to $217,067 in the current period as compared to net interest expense of $590,902 for the same period in the prior year, as we utilized less of our line of credit to finance receivables and inventory.

Income (Loss) from Continuing Operations Before Income Taxes

Income from continuing operations before income taxes for the current period was $288,648 compared to a loss from continuing operations before income taxes of $8,811,542 in the same period of the prior year.

Our tax provision (benefit) for the periods reflects an estimated effective rate of 38%.

As a result, income from continuing operations was $178,962 for the current year period compared to a loss from continuing operations of $5,463,157 in the comparable period of the prior year.

Income from discontinued operations, net of the tax effect, was $3,719 in the current year period due to sales of inventory from product returns processed during this quarter compared to income of $23,402,021 in the same period of the prior year.  The prior period includes a pretax gain of $34,277,316 from the sale of the Perry Ellis fragrance brand (See Note O to our condensed consolidated financial statements for further discussion).



5





As a result, net income for the three months ended December 31, 2007 was $182,681 as compared to net income of $17,938,864 in the corresponding prior year period.

Comparison of the nine-month period ended December 31, 2007 with the nine-month period ended December 31, 2006

Net Sales

During the nine months ended December 31, 2007, net sales from continuing operations increased 15% to $113,277,679 as compared to $98,785,112 for the same period for the prior year. The increase is mainly attributable to an increase of $29,818,654 in gross sales of Paris Hilton fragrance brands which included the recent launch of the new Can Can fragrance which commenced shipping in September 2007 and generated $5,500,267 in gross sales. Gross sales of Paris Hilton accessories increased by $1,360,106 over the same period in the prior year, as watch sales increased by $2,338,599, partially offset by a $978,493 decrease in handbag sales. Gross sales of GUESS? fragrances decreased $17,876,881 due to restrictions placed upon us by GUESS?, Inc. These restrictions are more fully discussed in Note J to our condensed consolidated financial statements.

Net sales to unrelated customers, which represented 58% of our total net sales for the nine-month period ended December 31, 2007, remained relatively constant at $65,493,977 compared to $65,377,336 for the same period in the prior year. As more fully discussed in Note F to our condensed consolidated financial statements, effective as of July 1, 2007, sales to certain distributors, that were previously reported as related parties, are now included as unrelated international customer sales. Net sales to the U.S. department store sector decreased 9% from $27,561,715 to $24,952,863, while net sales to international distributors increased 7% from $37,815,621 to $40,541,114. The increase in international net sales was primarily a result of growth in the Paris Hilton brand fragrances and accessories. This was partially offset by the reduced sales of GUESS? fragrance brands, as is more fully discussed in Note J to our condensed consolidated financial statements. Sales to related parties increased 43% to $47,783,702 compared to $33,407,776 for the same period in the prior year. The increase was attributable to increases of $23,832,164 in Paris Hilton brand fragrance sales, partially offset by reductions of $10,389,846 in GUESS? brand gross sales. We anticipate that this trend will continue as sales to Perfumania increase as a result of increased access to its distribution channels (See Note F to the condensed consolidated financial statements for further discussion of related parties).

Effective July 1, 2007, related party sales include only sales to Perfumania, as sales to certain distributors, that were previously reported as related parties, are now included as unrelated international customer sales.

Cost of Goods Sold

Our overall cost of goods sold decreased as a percentage of net sales to 51% for the nine months ended December 31, 2007, compared to 55% for the comparable prior year period. Cost of goods sold as a percentage of net sales to both unrelated customers and related parties approximated 51% for the current period, as compared to 57% and 52%, respectively, for the same period in the prior year. The prior year period included a higher percentage of sales of GUESS? products which sales, for the most part, have a lower margin than sales of our other products.

Total Operating Expenses

Total operating expenses decreased by 30% compared to the same period in the prior year from $73,668,482 to $51,224,419, decreasing as a percentage of net sales from 75% to 45%. However, certain individual components of our operating expenses discussed below experienced more significant changes than others.

Advertising and Promotional Expenses

Advertising and promotional expenses decreased 26% to $23,687,391, compared to $32,115,580 in the prior year period, decreasing as a percentage of net sales from 33% to 21%.  The current year period reflects a targeted effort on the part of management to control such expenses in the current year. During the current year period, we commenced a significant advertising campaign for the Paris Hilton fragrance brands in conjunction with the launch of Paris Hilton Can Can.  During the prior year period we incurred promotional costs in connection with the continued roll out of Paris Hilton and GUESS? fragrances for women and men on a worldwide basis and the launch of the Paris Hilton “Heiress” and GUESS? GOLD for women fragrances, mainly in U.S. department stores.



6





Selling and Distribution Costs

Selling and distribution costs decreased 10% to $8,575,452 compared to $9,577,421 in the prior year period, decreasing as a percentage of net sales from 10% to 8%. The decrease was mainly attributable to the centralization of all distribution activities in our New Jersey facility, resulting in a decrease of staff in our Florida warehouse facility.  The prior year period also included approximately $649,000 and $355,000 in additional costs for temporary warehouse storage space and freight charges for relocation of inventory to New Jersey, respectively.

Royalties

Royalties increased by 29% in the current period, from $7,171,624 to $9,240,576, increasing as a percentage of net sales from 7% to 8%. We anticipate that this percentage will remain relatively constant at 8% or decrease slightly for the remainder of the fiscal year ending March 31, 2008.

General and Administrative Expenses

General and administrative expenses decreased 68% compared to the same period in the prior year, from $23,133,606 to $7,500,119, decreasing as a percentage of net sales from 23% to 7%. The decreased amount was mainly attributable to a share-based compensation charge in the prior year period of $16,201,950 relating to the modification of warrants in connection with the Stock Split (See Note B to our condensed consolidated financial statements for further discussion).  The prior year period also included approximately $728,000 of additional legal expenses than the current year period, as various litigation was resolved during fiscal 2007.  These decreases were  partially offset by targeted additions to our accounting staff and an increase in professional fees of approximately $376,000 to focus our remediation efforts and mitigate the material weaknesses in our internal controls, as well as additional reserves for uncollectible accounts receivable of approximately $279,000.

Depreciation and Amortization

Depreciation and amortization increased 33% over the prior year period from $1,670,251 to $2,220,881, remaining constant at 2% of net sales.  The increased expense reflects the depreciation and amortization of equipment and leasehold improvements related to our New Jersey facility which were placed in service in September 2006, coupled with approximately $385,000 of impairment charges for the XOXO fragrance license.

Gain on Sale of Property Held for Sale

The prior year period included a gain of $494,465 from the sale of a warehouse facility in Sunrise, Florida. See Note M to our condensed consolidated financial statements for further discussion.

Operating Income (Loss)

As a result of the above factors, we generated operating income from continuing operations of $3,936,495 for the current period, compared to an operating loss from continuing operations of $29,049,432 for the same period in the prior year.

Other Income and Gain on Sale of Investment

During the nine months ended December 31, 2007, we reported other income primarily related to a $497,770 gain on an insurance recovery resulting from an inventory theft, which was in excess of the recorded value of the stolen inventory. The prior year period includes a gain from the sale of our investment in E Com Ventures, Inc. (“ECMV”) in the amount of $1,774,624. (See Note F to our condensed consolidated financial statements for further discussion).

Net interest expense

Net interest expense (including bank charges, and net of interest income) decreased 50% to $1,071,394 in the current period as compared to $2,125,124 for the same period in the prior year, as we utilized less of our line of credit to finance receivables and inventory.

Income (Loss) from Continuing Operations Before Income Taxes

Income from continuing operations before taxes for the current period was $3,372,905 compared to a net loss from continuing operations before taxes of $29,388,049 in the same period for the prior year. Our tax provision



7





for the current year period reflects an estimated effective rate of 38%. The effective rate in the prior period reflects (1) a limitation on the estimated deferred tax benefit that was expected to result from the share-based compensation charge related to the warrant modification, and (2) the $1,083,823 loss for income tax purposes resulting from the sale of our investment in ECMV (See Note F to our condensed consolidated financial statements for further discussion).  The benefit from the share-based compensation charge was limited by the maximum allowable annual compensation deduction for corporate officers under Section 162 (m) of the Internal Revenue Code. Consequently, the benefit recorded in the prior period reflected management’s best estimate at that time, based upon assumptions regarding the timing and market value of our common stock upon exercise of the warrants and the amount and nature of other forms of compensation to be paid to the holders of the warrants using the method in which cash compensation (salary and bonus) of the related individuals takes priority over the share-based compensation in determining the annual limitation. In February 2007, our former Chairman and CEO resigned. The estimated limitation on the deferred tax benefit that was expected to result from the share-based compensation charge related to the warrant modification was reviewed and adjusted accordingly at the time we reported our results of operations for the year ended March 31, 2007.

As a result, net income from continuing operations is $2,091,201 for the current period compared to a net loss of $22,233,088 in the comparable period of the prior year.

Income from discontinued operations net of the tax effect, was $25,350 in the current year period due to sales of inventory from product returns processed during this period, along with certain promotional costs related to Perry Ellis, compared to income of $29,700,305 in the same period of the prior year, including the pretax gain of $34,277,316 from the sale of the Perry Ellis fragrance brand (See Note O to the accompanying condensed consolidated financial statements for further discussion).

As a result, net income for the nine months ended December 31, 2007 was $2,116,551 as compared to net income of $7,467,217 in the corresponding prior year period.

Liquidity and Capital Resources

Working capital increased to $95,705,667 as of December 31, 2007, compared to $79,459,920 at March 31, 2007, primarily as a result of current period net income, the reduction in non-current inventory and the issuance of common stock in connection with the exercise of warrants.

During the nine months ended December 31, 2007, net cash provided by operating activities was $27,971,307 compared to net cash used in operating activities of $36,495,303 during the comparable prior year period. The current year activity reflects an increase in trade receivables, along with a decrease in accounts payable, offset by a refund of income taxes paid in the prior year, decreases in inventories and prepaid expenses and receipt of the remaining balance due from the sale of the Perry Ellis fragrance license. The prior year activity included significant increases in inventory balances, as well as increases in prepaid expenses and other current assets.

For the nine months ended December 31, 2007, net cash provided by investing activities was $740,685 as compared to net cash provided by investing activities of $79,874,778 in the prior comparable period. The prior year amount includes proceeds of $57,500,000 from the sale of the Perry Ellis fragrance brand and $17,935,850 from the sale of the Sunrise facility sold in 2006 (See Note M to our condensed consolidated financial statements for further discussion) and the sale of our investment in our affiliate, partially offset by purchases of equipment and leasehold improvements for our New Jersey distribution facility. The prior year period also included a decrease of $7,966,720 in restricted cash pending transfer to our lender (the current period had a decrease of $1,273,896.)

During the nine months ended December 31, 2007, net cash used in financing activities was $16,391,630 compared to cash used of $30,773,213 in the prior year comparable period. The current period reflects the repayments of our credit facility and an increase of $1,424,450 in proceeds from the issuance of common stock, while the prior year period includes repayments of our credit facility and the mortgage on our Sunrise, Florida facility, as well as the purchase of $2,499,424 in treasury stock.  

The net effect of our cash flow activity was an increase of approximately $12.3 million in our cash and cash equivalents.



8





As of December 31, 2007 and 2006, our ratios of the number of days sales in accounts receivable and number of days cost of sales in inventory, on an annualized basis, were as follows:

 

 

 

December 31,

 

 

 

 

2007

 

 

2006

 

Trade accounts receivable: 

 

 

 

 

 

 

 

Unrelated (1)

 

 

 

104

 

 

 

 

97

 

 

Related:

 

 

 

 

 

 

 

 

 

 

 

Perfumania

 

 

 

84

 

 

 

 

152

 

 

Other related (2)

 

 

 

 

 

 

 

63

 

 

Total

 

 

 

97

 

 

 

 

92

 

 

Inventories

 

 

 

274

 

 

 

 

395

 

 

———————

(1)

Calculated on gross trade receivables excluding allowances for doubtful accounts, sales returns and advertising allowances of approximately $6,763,000 and $8,253,000 in 2007 and 2006, respectively.

(2)

Effective July 1, 2007, we no longer classify certain international distributors as related parties.  See Note F to our condensed consolidated financial statements for further discussion.

The increase in the number of days from 2006 to 2007 for unrelated customers was mainly attributable to increased sales to international distributors, whose terms, for the most part, range from 60 to 90 days, compared to between 30 and 60 days for U.S. department store customers. Due to restrictions on sales of GUESS? products and delays in receiving GUESS? products, certain international distributors exceeded their payment terms. We anticipate collection of these past due balances over the next few months.  We anticipate the number of days for the unrelated customer group will range between 75 and 90 days during the balance of fiscal 2008.

The number of days sales in trade receivables from Perfumania previously exceeded those of our other customers, due mainly to our long-term relationship and their seasonal cash flow (See Note F to the accompanying condensed consolidated financial statements for further discussion of our relationship with Perfumania). Additionally, since sales to Perfumaina during our third quarter ended December 31, 2007 were less than each of the first and second quarters’ sales, the calculation of number of days sales in accounts receivable is shown as 84 days, on an annualized basis.  However, the actual number of days, based upon the actual ageing as of December 31, 2007, would be 112 days.  Management closely monitors our activity with Perfumania and holds periodic discussions with Perfumania management in order to review their anticipated payments for each quarter.

As noted in Note F to our condensed consolidated financial statements, effective as of July 1, 2007, transactions with such parties formerly identified as related, through their affiliation with our former Chairman and CEO, will no longer be reported as related party transactions. Their number of days sales are included with unrelated parties in the current period, and as other related for 2006.

Due to the significant number of new product launches during fiscal year 2007, and the forecasted sales increases for these products, in particular, the GUESS? branded products, the number of days sales in inventory  increased during the prior year. During the nine months ended December 31, 2007, the number of days sales in inventory decreased in conjunction with management’s targeted efforts to reduce inventory levels. We anticipate that this trend will continue to improve over the next year, as these launched products reach full distribution and GUESS? approves additional international distribution channels (See Note J to our condensed consolidated financial statements for further discussion). As of December 31, 2007, $8,143,000 of our inventory, including $6,333,000 related to GUESS? brand products, has been classified as non-current. As of March 31, 2007, $17,392,000 of our inventory, including $16,150,000 related to GUESS? brand products had been classified as non-current. We have revised our production and purchasing forecasts in order to improve our inventory management.  We believe that the carrying value of our inventory at December 31, 2007, based on current conditions, is stated at the lower of cost or market.

On July 20, 2001, we entered into a Loan and Security Agreement (the “Loan Agreement”) with GMAC Commercial Credit LLC (“GMACCC”). On January 4, 2005, the Loan Agreement was extended through July 20, 2006. Under the Loan Agreement, we were able to borrow, depending upon the availability of a borrowing base, on a revolving basis, up to $20,000,000 at an interest rate of LIBOR plus 2.75% or the Bank of New York’s prime rate, at our option.



9





On January 10, 2006, the Loan Agreement was amended, increasing the loan amount to $30,000,000, with an additional $5,000,000 available at our option, while extending the maturity to July 20, 2008. The interest was reduced to .25% below the prime rate. During May 2006, we exercised our option and increased the line to $35,000,000.

At December 31, 2007, based on the borrowing base at that date, the credit line amounted to $29,319,000, of which there was no balance outstanding. Accordingly, we had this entire amount available under the credit line. Restricted cash represents collections of trade accounts receivable deposited with our bank and pending transfer to GMACCC. As of March 31, 2007, $1,273,896 was on deposit with our bank pending transfer.  As of December 31, 2007 the restricted cash balance was zero.  

Substantially all of our assets, excluding our New Jersey warehouse equipment, collateralize our credit line borrowing. The Loan Agreement contains customary events of default and covenants which prohibit, among other things, incurring additional indebtedness in excess of a specified amount, paying dividends, creating liens, and engaging in mergers and acquisitions without the prior consent of GMACCC. As of March 31, 2007, we were not in compliance with the fixed charge covenant. We requested an amendment of the Loan Agreement from our lender, which was granted on June 27, 2007, and which revised such covenant through March 31, 2008. As of December 31, 2007 and September 30, 2007, we were not in compliance with our minimum earnings before income taxes, depreciation and amortization (“EBITDA”) requirements. We requested amendments of our agreement from our lender, which were granted on February 6, 2008 and November 9, 2007, respectively, and which revised such covenant at those dates. The Loan Agreement, as amended, also contains certain financial covenants relating to net worth, interest coverage and other financial ratios, which we were in compliance with as of December 31, 2007.

As of December 31, 2007, we did not have any “off-balance sheet” arrangements as that term is defined in Regulation S-K 303, nor did we have any material commitments for capital expenditures.

Contractual Obligations

On November 30, 2007, we entered into an eight (8) year  lease agreement, commencing during February 2008, for 19,072 square feet of office space in Fort Lauderdale, Florida, which will serve as our new corporate headquarters.  We anticipate moving during the second week in February 2008 from our present 99,000 square foot office/warehouse facility, which is currently being marketed for sublease.  Annual rental on the new headquarters approximates $534,000 during the initial term, increasing 3% per annum thereafter.

Apart from the new office lease, discussed above, there were no material changes during the quarter ended December 31, 2007 in our contractual obligations previously disclosed in our Annual Report on Form 10-K for the year ended March 31, 2007.

Item 3.

Quantitative and Qualitative Disclosures About Market Risks

During the quarter ended December 31, 2007, there have been no material changes to our exposures to market risks since March 31, 2007. Please refer to our Annual Report on Form 10-K for the year ended March 31, 2007 for a complete discussion of our exposures to market risk.

Item 4.

Controls and Procedures

Parlux Fragrances, Inc.’s Chief Executive Officer (its principal executive officer) and Chief Financial Officer (its principal financial officer) have evaluated the effectiveness of the Company’s disclosure controls and procedures (as defined in Rule 13a-15(e) of the Securities Exchange Act of 1934), as of the end of the period covered by this report, based on the evaluation required by paragraph (b) of Rule 13a-15 under the Securities Act of 1934. They have concluded that, as of such date, several material weaknesses existed in our internal controls over financial reporting and consequently, the Company’s disclosure controls and procedures were not effective as of the end of the period covered by this Quarterly Report.



10





Changes in internal control

Material weaknesses previously identified and remediated as of December 31, 2007

Management identified material weaknesses which were reported in our quarterly report on Form 10-Q for the quarter ended September 30, 2007.  In an effort to remediate some of these material weaknesses, management has made changes to certain internal controls over financial reporting, including the following:

1.

A number of Executive Management changes were made effective February 2007 to address the weaknesses identified in the Company’s internal control procedures initially identified as of March 31, 2006. The Board of Directors was reorganized and a new Chairman and Chief Executive Officer was appointed. The Company also appointed a new Chief Financial Officer in May 2007, to segregate duties previously performed by the Company’s Executive Vice President and Chief Operating Officer. Management developed an Audit Committee Review File which is provided to the Chair of the Audit Committee prior to the finalization of the Company’s Annual and Quarterly Reports on Forms 10-K and 10-Q. This file provides supporting documentation for all significant areas where estimates and the potential for management override could exist.

2.

The Company hired additional employees in finance and accounting, and revised duties within accounts payable and accounts receivable to segregate incompatible functions.

3.

Access to master files has been restricted and the Company implemented procedures whereby computer generated reports are prepared daily, identifying all changes to the accounts payable and accounts receivable master files. These reports are reviewed by a designated employee independent of the respective department’s activities.

4.

The Company implemented specific procedures for processing adjustments to accounts payable, including potential credits thereto.

As a result of changes in internal controls, the following material weaknesses in our internal control over financial reporting have been remediated during the quarter ended December 31, 2007, as follows:

1.

Lack of sufficient resources in our accounting and finance organization − The Company did not maintain a sufficient complement of personnel to maintain an appropriate accounting and financial reporting structure to support the activities of the Company. As of March 31, 2007, the Company had an insufficient number of personnel with clearly delineated and fully documented responsibilities to timely prepare and file its yearend financial statements and Annual Report on Form 10−K. In addition, the Company’s former Chief Financial Officer was responsible for preparing or compiling certain critical portions of the quarterly and annual financial information and was often responsible for performing the final review of this information.

2.

Lack of sufficient resources to provide for suitable segregation of duties − In connection with the lack of sufficient accounting and finance resources described above, certain financial and accounting personnel had incompatible duties that permitted creation, review, processing and potential management override of certain financial data without independent review and authorization. The increase in the Company’s administrative staffing had not been commensurate with the growth in the volume of business transactions.

3.

Inadequate access controls with regard to computer master file information − Certain of the Company’s personnel in accounts payable and accounts receivable had access and could make changes to master files without approval.

4.

Inadequate controls over the processing of adjustments to accounts payable − The internal controls over accounts payable were not designed or operating in a manner to effectively support the expenditure cycle. Certain adjustments were not processed timely and with proper approval. This material weakness was the result of aggregate deficiencies in internal control activities.

Pursuant to Exchange Act Rule 13a-15(d), this effort constituted a material change to the internal control structure and is consistent with management’s assessment that the previously mentioned material weaknesses were remediated.



11





Material weaknesses previously identified but not remediated as of December 31, 2007

Our management has reviewed the material weaknesses described below with our Audit Committee. To remediate these material weaknesses, we have implemented and continue to implement a number of changes to our internal control over financial reporting, including the following:

1.

All charge-backs for demonstration costs must be approved by the Vice President of Domestic Sales.

2.

Advertising expenditures and commitments are being reviewed as part of the month end closing process to determine that billings have been received or accrued during that reporting period.

3.

Additional computer reports, listing all changes to the inventory master files are prepared daily. These reports are reviewed by a designated employee independent of the respective department’s activity. Additional personnel have been added to the department and the Company has implemented a procedure to reconcile significant inventory balances at third party locations on a periodic basis.

The Company will continue to fully test and assess the effectiveness of the internal control improvements that were implemented during the nine months ended December 31, 2007.

The following previously identified material weaknesses remain at December 31, 2007, as follows:

1.

Inadequate controls over the processing of certain credits to accounts receivable − The Company receives chargebacks from its customers for a variety of items. The internal controls were not adequately designed or operating in a manner to effectively support the requirements of the sales and expenditure cycles. This material weakness is the result of aggregate deficiencies in internal control activities and could result in a material misstatement of trade receivables and advertising and promotional cost that would not be prevented or detected.

2.

Inadequate controls over the processing of certain expenses, most notably, advertising and promotional expenses − Costs relating to the advertisement and promotion of the Company’s products are a significant cost of operations. The internal controls were not adequately designed or operating in a manner to establish specific controls to ensure that all advertising and promotional expenses were approved and processed on a timely basis. This material weakness is the result of aggregate deficiencies in internal control activities and could result in a material misstatement of accounts payable, accrued expenses and advertising and promotional cost that would not be prevented or detected.

3.

Inadequate controls related to the inventory cycle - The internal controls over inventories were not adequately designed or operating in a manner to ensure timely review and approval of changes to the inventory master files; the completeness and accuracy of inventory stored at third party locations including updating of accounting records for inventory movement and receipts; and accuracy of costing and valuation of inventory. This material weakness is the result of aggregate deficiencies in internal control activities and could result in a material misstatement of inventory and cost of sales balances that would not be prevented and detected.

In light of the material weaknesses described above, in preparing our financial statements as of and for the quarter ended December 31, 2007, we performed additional procedures to ensure that such financial statements were fairly presented in all material respects in accordance with generally accepted accounting principles. Notwithstanding the material weaknesses listed above, management believes that the condensed consolidated financial statements included in this Quarterly Report on Form 10-Q fairly present, in all material respects, the Company’s financial condition, results of operations and cash flows for the periods and dates presented.



12





PART II. – OTHER INFORMATION

Item 1.

Legal Proceedings

Litigation

On June 21, 2006, we were served with a stockholder derivative action (the “Derivative Action”) filed in the Circuit Court of the Seventeenth Judicial Circuit in and for Broward County, Florida by NECA-IBEW Pension Fund, purporting to act derivatively on behalf of the Company.

The Derivative Action named Parlux Fragrances, Inc. as a defendant, along with Ilia Lekach, Frank A. Buttacavoli, Glenn Gopman, Esther Egozi Choukroun, David Stone, Jaya Kader Zebede and Isaac Lekach, each of whom at that date was one of our directors. The Derivative Action related to the proposal from PF Acquisition of Florida LLC (“PFA”), which was owned by Ilia Lekach, to acquire all of our outstanding shares of common stock for $29.00 ($14.50 after the Stock Split) per share in cash (the “Proposal”).

The Derivative Action seeks to remedy the alleged breaches of fiduciary duties, waste of corporate assets, and other violations of law and seeks injunctive relief from the Court appointing a receiver or other truly neutral third party to conduct and/or oversee any negotiations regarding the terms of the Proposal, or any alternative transaction, on behalf of Parlux and its public shareholders, and to report to the Court and plaintiff’s counsel regarding the same. The Derivative Action alleges that the unlawful plan to attempt to buy out the public shareholders of Parlux without having proper financing in place, and for inadequate consideration, violates applicable law by directly breaching and/or aiding the other defendants’ breaches of their fiduciary duties of loyalty, candor, due care, independence, good faith and fair dealing, causing the complete waste of corporate assets, and constituting an abuse of control by the defendants. Before any response to the original complaint was due, counsel for plaintiffs indicated that an amended complaint would be filed. That First Amended Complaint (the "Amended Complaint") was served to our counsel on August 17, 2006.

The Amended Complaint continues to name the then Board of Directors as defendants along with Parlux, as a nominal defendant. The Amended Complaint is largely a collection of claims previously asserted in a 2003 derivative action, which the plaintiffs in that action, when provided with additional information, simply elected not to pursue. It adds to those claims, assertions regarding a 2003 buy-out effort and the recently abandoned buy-out effort of PFA. It also contains allegations regarding the prospect that the Company's stock might be delisted because of a delay in meeting Securties and Exchange Commission (“SEC”) filing requirements. It relies in large measure on a bevy of media articles rather than facts known to the plaintiffs.

We and the other defendants engaged Florida securities counsel, including the counsel who successfully represented us in the previous failed derivative action, and on September 18, 2006, moved to dismiss the Amended Complaint. A Second Amended Complaint was filed on October 26, 2006, which added alleged violations of securities laws, which we moved to dismiss on December 1, 2006. A hearing on the dismissal was held on March 8, 2007. On March 22, 2007, the motion to dismiss was denied and the defendants were provided twenty (20) days to respond, and a response was filed on March 29, 2007. Since that time there has been extremely limited discovery conducted in the case. Some documents have been produced. Narrow interrogatories were answered. There have been no depositions and none has even been scheduled. A number of the factual allegations upon which the various complaints were based have fallen away, simply by operation of time. Based on the allegations in the Second Amended Complaint, upon the information collected in the earlier litigation and upon the information provided in response to the limited discovery noted above, it is believed that the Second Amended complaint is without merit.

Victory Litigation

On August 16, 2006, we entered into a letter of intent to sell our Perry Ellis fragrance rights to Victory International (USA) LLC (“Victory”) for a total of up to $140 million: $120 million for the fragrance rights, payable in sixty (60) monthly installments of $2 million, without interest, and up to $20 million for inventory due at closing. The letter of intent was subject to the execution of a definitive agreement and the approvals associated therewith, including approval by the licensor, PEI. On October 9, 2006, PEI informed us that they would not consent to the assignment of the rights. Victory had paid a deposit of $1 million to us in connection with the letter of intent, which was refunded during October 2006.

On December 6, 2006, we entered into an agreement to sell the Perry Ellis fragrance rights and related assets, including inventory, molds and other intangible assets related thereto, to PEI, at a price of approximately



13





$63 million, subject to final inventory valuations. The closing took place shortly thereafter. We recorded a pre-tax gain of approximately $34.3 million on the sale for the year ended March 31, 2007.

On March 2, 2007, Parlux, Ilia Lekach and Frank Buttacavoli were named as defendants, along with Perry Ellis International, Inc. and its Chairman and CEO, George Feldenkreis, Rene Garcia, Quality King Distributors, Inc., E Com Ventures, Perfumania, Model Reorg, Inc., Glenn Nussdorf, DFA Holdings, Inc., Duty Free Americas, Inc., Falic Fashion Group, LLC, Simon Falic and Jerome Falic. This action by plaintiff Victory relates to PEI’s failure to consent to the assignment by us of its contractual license to the Perry Ellis brand of perfumes. The plaintiff is alleging that PEI unreasonably withheld its consent and, instead, conspired with a variety of people to prevent Victory from obtaining this license. No direct allegations are made against us. The allegations against Messrs. Lekach and Buttacavoli relate to the recent attempt by Glenn Nussdorf to replace all of our directors with his nominees. The First Amended Complaint alleges that Mr. Nussdorf and certain affiliates are among the alleged co-conspirators with PEI to prevent Victory from obtaining the license.

On May 18, 2007, we filed a motion to dismiss on behalf of Parlux, Messrs. Lekach and Buttacavoli on the basis that the complaint fails to state a cause of action against any of them. All other defendants moved to dismiss as well, on a host of different theories. At the same time we moved to transfer the case from the District of New Jersey to the Southern District of Florida, a motion in which 14 of the 17 defendants joined. After a hearing in December, the District Court in New Jersey granted the motion to transfer on January 2, 2008, and ordered the case transferred to the Southern District of Florida. The motions to dismiss are traveling with the case as is the customary practice. It is expected that the Florida Court will rule on those pending motions sometime in the last Spring or early Summer. There has been no discovery conducted. Plaintiff’s request for preliminary discovery to address jurisdictional issues was denied by the Court. Based on very preliminary analysis, since there has been no discovery to date, it appears that the Company and the individual defendants have meritorious defenses to all of the claims asserted.

To the best of our knowledge, there are no other proceedings threatened or pending against us, which, if determined adversely to us, would have a material effect on our financial position or results of operations and cash flows.

Item 1A.

Risk Factors

There were no material changes during the quarter ended December 31, 2007 in the risk factors previously disclosed in our Annual Report on Form 10-K for the year ended March 31, 2007.

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds

None.

Item 3.

Defaults on Senior Securities

None.

Item 4.

Submission of Matters to a Vote of Security Holders

The Company held its Annual Meeting of Stockholders on October 11, 2007.  The following is a summary of the proposals and corresponding votes.

Nomination and Election of Directors and Approval of Stock Incentive Plan

All six nominees named in the proxy statement were elected with each director receiving votes as follows:


Nominee

For

Withheld

Neil J. Katz

15,735,177

   576,644

Anthony D’Agostino

15,473,443

   838,378

Esther Egozi Choukroun

15,294,166

1,017,655

Glenn H. Gopman

15,178,786

1,133,035

Robert Mitzman

15,469,693

   882,128

David Stone

15,056,666

1,255,155



14








The Parlux Fragrances, Inc. 2007 Stock Incentive Plan was approved by stockholders as follows:


For

Against

Abstain

6,947,841

2,717,882

130,952

Item 5.

Other Information

None.

Item 6.

Exhibits

Exhibit #

 

Description

10.2

 

The Parlux Fragrances, Inc. 2007 Stock Incentive Plan (incorporated by reference to Exhibit 10.2 to the Company’s registration on Form S-8, filed on December 28, 2007.)

10.86

 

Office Sublease Agreement, dated as of November 30, 2007, between the Company and Tarragon South Development Corp.

31.1

 

Certification of Chief Executive Officer Pursuant to §302 of the Sarbanes-Oxley Act of 2002.

31.2

 

Certification of Chief Financial Officer Pursuant to §302 of the Sarbanes-Oxley Act of 2002.

32.1

 

Certification of Chief Executive Officer Pursuant to §906 of the Sarbanes-Oxley Act of 2002.

32.2

 

Certification of Chief Financial Officer Pursuant to §906 of the Sarbanes-Oxley Act of 2002.




15





PARLUX FRAGRANCES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

 

 

December 31,
2007

 

March 31,
2007

 

ASSETS

 

(Unaudited)

 

 

 

CURRENT ASSETS:

     

 

 

     

 

 

 

Cash and cash equivalents

 

$

12,334,633

 

$

14,271

 

Restricted cash

 

 

 

 

1,273,896

 

Trade receivables, net of allowance for doubtful accounts,
sales returns and advertising allowances of approximately
$6,763,000 and $6,155,000, respectively

 

 

21,100,973

 

 

11,508,224

 

Trade receivables from related parties

 

 

12,088,389

 

 

14,032,462

 

Income tax receivable

 

 

3,192,366

 

 

8,820,296

 

Receivable from sale of fragrance brand

 

 

 

 

2,295,904

 

Inventories

 

 

46,821,661

 

 

56,183,036

 

Prepaid expenses and other current assets, net

 

 

9,754,982

 

 

15,006,230

 

Deferred tax assets, net

 

 

4,930,555

 

 

4,930,555

 

TOTAL CURRENT ASSETS

 

 

110,223,559

 

 

114,064,874

 

Inventories, non-current

 

 

8,143,000

 

 

17,392,000

 

Equipment and leasehold improvements, net

 

 

3,569,913

 

 

4,286,194

 

Trademarks and licenses, net

 

 

2,941,394

 

 

3,912,783

 

Deferred tax assets, net

 

 

2,294,737

 

 

4,823,091

 

Other

 

 

296,850

 

 

417,489

 

TOTAL ASSETS

 

$

127,469,453

 

$

144,896,431

 

LIABILITIES AND STOCKHOLDERS' EQUITY

 

 

 

 

 

 

 

CURRENT LIABILITIES:

 

 

 

 

 

 

 

Borrowings, current portion

 

$

973,320

 

$

17,697,616

 

Accounts payable

 

 

9,770,938

 

 

14,496,090

 

Income taxes payable

 

 

166,699

 

 

 

Accrued expenses

 

 

3,606,935

 

 

2,411,248

 

TOTAL CURRENT LIABILITIES

 

 

14,517,892

 

 

34,604,954

 

Borrowings, less current portion

 

 

797,942

 

 

1,536,959

 

TOTAL LIABILITIES

 

 

15,315,834

 

 

36,141,913

 

COMMITMENTS  AND CONTINGENCIES

 

 

 

 

 

 

 

STOCKHOLDERS' EQUITY :

 

 

 

 

 

 

 

Preferred stock, $0.01 par value, 5,000,000 shares authorized,
no shares issued and outstanding at December 31, 2007
and March 31, 2007

 

 

 

 

 

Common stock, $0.01 par value, 30,000,000 shares authorized,
29,977,289 and 29,417,289 shares issued as of December 31, 2007  
and March 31, 2007, respectively

 

 

299,773

 

 

294,173

 

Additional paid-in capital

 

 

101,551,065

 

 

102,018,217

 

Retained earnings

 

 

45,353,427

 

 

45,618,841

 

 

 

 

147,204,265

 

 

147,931,231

 

Less - 9,832,377 and 11,347,377 shares of common stock in treasury,
at cost, at December 31, 2007 and March 31, 2007, respectively

 

 

(35,050,646

)

 

(39,176,713

)

TOTAL STOCKHOLDERS' EQUITY

 

 

112,153,619

 

 

108,754,518

 

TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY

 

$

127,469,453

 

$

144,896,431

 



See notes to condensed consolidated financial statements.

16





PARLUX FRAGRANCES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited)


 

 

Three Months Ended December 31,

 

Nine Months Ended
December 31,

 

 

 

2007

 

2006

 

2007

 

2006

 

Net sales:

     

 

 

 

 

 

 

 

 

 

 

 

 

Unrelated customers, including licensing fees of  $18,750 and $56,250 for the three and nine months ended December 31, 2007 and 2006, respectively

 

$

35,055,318

 

$

29,738,731

 

$

65,493,977

 

$

65,377,336

 

Related parties

 

 

9,488,470

 

 

13,677,578

 

 

47,783,702

 

 

33,407,776

 

 

 

 

44,543,788

 

 

43,416,309

 

 

113,277,679

 

 

98,785,112

 

Cost of goods sold

 

 

 

 

 

 

 

 

 

 

 

 

 

Unrelated customers

 

 

17,143,476

 

 

18,078,930

 

 

33,667,982

 

 

37,216,966

 

Related parties

 

 

5,009,970

 

 

7,242,803

 

 

24,448,783

 

 

17,443,561

 

 

 

 

22,153,446

 

 

25,321,733

 

 

58,116,765

 

 

54,660,527

 

Operating expenses:

 

 

 

 

 

 

 

 

 

 

 

 

 

Advertising and promotional

 

 

12,454,247

 

 

16,018,065

 

 

23,687,391

 

 

32,115,580

 

Selling and distribution

 

 

3,358,058

 

 

3,874,413

 

 

8,575,452

 

 

9,577,421

 

Royalties

 

 

3,301,514

 

 

2,918,811

 

 

9,240,576

 

 

7,171,624

 

General and administrative, (including share-based compensation expense of $210,867 for the three and nine months ended December 31, 2007 and $16,201,950 for the nine months ended December 31, 2006

 

 

1,975,670

 

 

2,833,276

 

 

7,500,119

 

 

23,133,606

 

Depreciation and amortization

 

 

807,013

 

 

668,203

 

 

2,220,881

 

 

1,670,251

 

Total operating expenses

 

 

21,896,502

 

 

26,312,768

 

 

51,224,419

 

 

73,668,482

 

Gain on sale of property held for sale

 

 

 

 

 

 

 

 

494,465

 

Operating income (loss)

 

 

493,840

 

 

(8,218,192

)

 

3,936,495

 

 

(29,049,432

)

Other income (expense):

 

 

 

 

 

 

 

 

 

 

 

 

 

Interest income

 

 

4,959

 

 

27,287

 

 

5,052

 

 

44,558

 

Interest expense and bank charges

 

 

(222,026

)

 

(618,189

)

 

(1,076,446

)

 

(2,169,682

)

Gain on sale of investment in affiliate

 

 

 

 

 

 

 

 

1,774,624

 

Other income

 

 

 

 

 

 

497,770

 

 

 

Foreign exchange (loss) gain

 

 

11,875

 

 

(2,448

)

 

10,034

 

 

11,883

 

Income (loss) from continuing operations before income taxes

 

 

288,648

 

 

(8,811,542)

 

 

3,372,905

 

 

(29,388,049

)

Income tax (provision) benefit

 

 

(109,686

)

 

3,348,385

 

 

(1,281,704

)

 

7,154,961

 

Income (loss) from continuing operations

 

 

178,962

 

 

(5,463,157

)

 

2,091,201

 

 

(22,233,088

)

Discontinued operations (Note O):

 

 

 

 

 

 

 

 

 

 

 

 

 

Income from operations of Perry Ellis fragrance brand

 

 

5,999

 

 

37,745,195

 

 

40,887

 

 

47,903,718

 

Income tax provision related to Perry Ellis brand

 

 

(2,280

)

 

(14,343,174

)

 

(15,537

)

 

(18,203,413

)

Income from discontinued operations

 

 

3,719

 

 

23,402,021

 

 

25,350

 

 

29,700,305

 

Net income

 

$

182,681

 

$

17,938,864

 

$

2,116,551

 

$

7,467,217

 

Income (loss) per common share:

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic:

 

 

 

 

 

 

 

 

 

 

 

 

 

Continuing operations

 

$

0.01

 

$

(0.30

)

$

0.11

 

$

(1.23

)

Discontinued operations

 

$

0.00

 

$

1.28

 

$

0.00

 

$

1.64

 

Total

 

$

0.01

 

$

0.98

 

$

0.11

 

$

0.41

 

Diluted:

 

 

 

 

 

 

 

 

 

 

 

 

 

Continuing operations

 

$

0.01

 

$

(0.30

)

$

0.10

 

$

(1.23

)

Discontinued operations

 

$

0.00

 

$

1.28

 

$

0.00

 

$

1.64

 

Total

 

$

0.01

 

$

0.98

 

$

0.10

 

$

0.41

 



See notes to condensed consolidated financial statements.

17





PARLUX FRAGRANCES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY

NINE MONTHS ENDED DECEMBER 31, 2007

(Unaudited)


 

 

 

Common Stock

 

Additional
Paid-In
Capital

 

Retained
Earnings

 

 

Treasury Stock

 

Total

 

 

Number
Issued

 

Par
Value

 

Number
of Shares

 

Cost

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance at
April 1, 2007

     

 

29,417,289

     

$

294,173

     

$

102,018,217

     

$

45,618,841

     

 

11,347,377

     

$

(39,176,713

)     

$

108,754,518

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income

 

 

 

 

 

 

 

 

 

 

 

2,116,551

 

 

 

 

 

 

 

 

2,116,551

 

Excess tax deficiency

 

 

 

 

 

 

 

 

(1,268,307

)

 

 

 

 

 

 

 

 

 

 

(1,268,307

)

Issuance of common stock upon exercise of warrants

 

 

560,000

 

 

5,600

 

 

590,288

 

 

 

 

 

 

 

 

 

 

 

595,888

 

Issuance of common stock
from treasury shares upon exercise of warrants

 

 

 

 

 

 

 

 

 

 

 

(2,381,965

)

 

(1,515,000

)

 

4,126,067

 

 

1,744,102

 

Share-based compensation from option grants

 

 

 

 

 

 

 

 

210,867

 

 

 

 

 

 

 

 

 

 

 

210,867

 

Balance at December 31, 2007

 

 

29,977,289

 

$

299,773

 

$

101,551,065

 

$

45,353,427

 

 

9,832,377

 

$

(35,050,646

)

$

112,153,619

 



See notes to condensed consolidated financial statements.

18





PARLUX FRAGRANCES, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)


 

 

Nine Months Ended
December 31,

 

 

 

2007

 

2006

 

Cash flows from operating activities:

     

 

 

     

 

 

 

Net income

 

$

2,116,551

 

$

7,467,217

 

Adjustments to reconcile net income to net cash
provided by (used in) operating activities:

 

 

 

 

 

 

 

Share-based compensation expense

 

 

210,867

 

 

16,201,950

 

Gain on sale of property held for sale

 

 

 

 

(494,465

)

Gain on sale of Perry Ellis fragrance brand

 

 

 

 

 

(34,277,316

)

Gain on sale of investment in affiliate

 

 

 

 

(1,774,624

)

Depreciation and amortization

 

 

2,220,881

 

 

1,670,251

 

Provision for doubtful accounts

 

 

718,719

 

 

440,000

 

Write downs of prepaid promotional supplies and inventories

 

 

855,000

 

 

1,255,000

 

Deferred income tax benefit

 

 

 

 

(1,058,034

)

Changes in assets and liabilities:

 

 

 

 

 

 

 

(Increase) decrease in trade receivables - customers

 

 

(10,311,468

)

 

824,145

 

Decrease (increase) in trade receivables - related parties

 

 

1,944,073

 

 

(1,013,436

)

Decrease in receivable from sale of fragrance brand

 

 

2,295,904

 

 

 

Decrease in income tax receivable

 

 

5,627,930

 

 

 

Decrease (increase) in inventories, current

 

 

8,686,375

 

 

(29,199,666

)

Decrease (increase) in prepaid expenses and other current assets

 

 

5,071,248

 

 

(4,329,525

)

Decrease in inventories, non-current

 

 

9,249,000

 

 

 

Decrease in deferred tax asset

 

 

2,528,354

 

 

 

Decrease in other non-current assets

 

 

120,639

 

 

47,786

 

Decrease in accounts payable

 

 

(4,725,152

)

 

(2,102,433

)

Increase in accrued expenses and income taxes payable

 

 

1,362,386

 

 

9,847,847

 

Total adjustments

 

 

25,854,756

 

 

(43,962,520

)

Net cash provided by (used in) operating activities

 

 

27,971,307

 

 

(36,495,303

)

Cash flows from investing activities:

 

 

 

 

 

 

 

Proceeds from sale of Perry Ellis fragrance brand

 

 

 

 

 

57,500,000

 

Redemption of certificate of deposit

 

 

 

 

1,026,534

 

Net decrease in restricted cash

 

 

1,273,896

 

 

7,966,720

 

Purchases of equipment and leasehold improvements, net

 

 

(327,799

)

 

(4,314,671

)

Purchases of trademarks

 

 

(205,412

)

 

(239,655

)

Net proceeds from the sale of property held for sale

 

 

 

 

14,512,703

 

Net proceeds from the sale of investment in affiliate

 

 

 

 

3,423,147

 

Net cash provided by investing activities

 

 

740,685

 

 

79,874,778

 

Cash flows from financing activities:

 

 

 

 

 

 

 

Repayments - line of credit with GMACCC, net

 

 

(16,775,318

)

 

(19,081,787

)

Proceeds - capital leases with Provident Equipment Leasing, net

 

 

 

 

2,761,266

 

Repayment - mortgage payable on property held for sale

 

 

 

 

(12,868,808

)

Repayments on capital leases

 

 

(687,995

)

 

 

Excess tax deficiency resulting from exercise of warrants

 

 

(1,268,307

)

 

 

Purchases of treasury stock

 

 

 

 

(2,499,424

)

Proceeds from exercise of warrants

 

 

595,888

 

 

915,540

 

Proceeds from Issuance of common stock from treasury shares
due to exercise of warrants

 

 

1,744,102

 

 

 

Net cash used in financing activities

 

 

(16,391,630

)

 

(30,773,213

)

Effect of exchange rate changes on cash

 

 

 

 

(56

)

Net increase in cash and cash equivalents

 

 

12,320,362

 

 

12,606,206

 

Cash and cash equivalents, beginning of period

 

 

14,271

 

 

49,822

 

Cash and cash equivalents, end of period

 

$

12,334,633

 

$

12,656,028

 




See notes to condensed consolidated financial statements.

19





PARLUX FRAGRANCES, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

A.

Basis of Presentation

Parlux Fragrances, Inc. is a manufacturer and international distributor of prestige products. It holds licenses for Paris Hilton fragrances, watches, cosmetics, sunglasses, handbags and other small leather accessories in addition to licenses to manufacture and distribute the designer fragrance brands of GUESS?, Jessica Simpson, Nicole Miller, XOXO, Ocean Pacific (OP), Maria Sharapova, Andy Roddick, babyGund, and Fred Hayman Beverly Hills.

The accompanying condensed consolidated financial statements include the accounts of Parlux Fragrances, Inc., and its wholly-owned subsidiaries, Parlux, S.A., a French company (“S.A.”), and Parlux Ltd. (jointly referred to as the “Company”). All material intercompany balances and transactions have been eliminated in consolidation.

On May 17, 2006, the Company announced a two-for-one stock split of common stock in the form of a dividend, for stockholders of record on May 31, 2006 (the “Stock Split”). The Stock Split was effected on June 16, 2006 and did not include shares held in treasury. The par value of the common stock remains at $0.01 per share.

The accompanying unaudited condensed consolidated financial statements have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”). Certain information and disclosures normally included in annual financial statements prepared in accordance with accounting principles generally accepted in the United States of America (“United States” or “US”) have been omitted pursuant to those rules and regulations, although the Company believes that the disclosures made herein are adequate to make the information presented not misleading. The financial information presented herein, which is not necessarily indicative of results to be expected for the entire current fiscal year, reflects all adjustments (consisting only of normal recurring accruals), which, in the opinion of management, are necessary for a fair presentation of the interim unaudited condensed consolidated financial statements. It is suggested that these condensed consolidated financial statements be read in conjunction with the financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended March 31, 2007.

B.

Share-Based Compensation

On October 11, 2007, the Company’s stockholders approved the Parlux Fragrances, Inc. 2007 Stock Incentive Plan (the “2007 Plan”), which reserved an additional 1,500,000 shares of common stock for equity-based awards to employees, officers, directors, consultants and/or independent contractors of the Company.  The 2007 Plan was adopted by the Board of Directors on June 20, 2007, subject to stockholder approval.

On October 11, 2007, the Company granted 240,000 options under the 2007 Plan to certain executives in connection with their July 2007 employment agreements, and 75,000 options (15,000 each) to its five non-employee directors, to acquire common stock during a five-year period at $4.60 per share, the closing price of stock on October 11, 2007. The directors’ options vested on the grant date, while the executives’ options vest over a three-year period at the annual rate of 40,000, 80,000 and 120,000, respectively.  The fair value of the combined October 11, 2007 options was determined to be $728,784.  The directors’ options were expensed as share-based compensation during the current quarter, while the executives’ options will be expensed as share-based compensation over a three year period in accordance with the applicable vesting periods.

The fair value of these options at the date of grant was estimated using a Black-Scholes option pricing model with the following weighted average assumptions.

Expected life (years)

 

 

3

 

Expected volatility

 

 

70

%

Risk-free interest rate

 

 

6

%

Dividend yield

 

 

0

%

The expected life of all of the various options and warrants represented the estimated period of time until exercise based on historical experience of similar awards, giving consideration to the remaining contractual terms and expectations of future employee behavior. The expected volatility was estimated using the historical volatility of the Company's stock which management believes is the best indicator at this time. The risk-free interest rate was



20





based on the implied yield available on U.S. Treasury zero coupon issues with an equivalent term. The Company has not paid dividends in the past and does not intend to in the foreseeable future.

The Company had two stock option plans which provide for equity-based awards to its employees other than its directors and officers (collectively, the "Employee Plans"). Under the Employee Plans, the Company reserved 1,000,000 shares of common stock; 470,774 options (including 102,500 granted during August 2007 discussed below) were granted of which 368,274 were exercised. All stock options had an exercise price that was equal to the fair market value of the Company's stock on the date the options were granted. The term of the stock option awards is five years from the date of grant. In addition, the Company had previously issued 3,440,000 warrants to certain officers, employees, consultants and directors (919,000 of which are outstanding at December 31, 2007), all of which were granted at or in excess of the market value of the underlying shares at the date of grant, and are exercisable for a ten-year period.

Effective April 1, 2006, the beginning of the Company's first quarter of fiscal 2007, the Company became subject to the fair value recognition provisions of Statement of Financial Accounting Standards ("SFAS") No. 123R "Share Based Payment" (“SFAS No. 123R”), using the modified-prospective transition method. Under this transition method, share based compensation expense is required to be recognized in the consolidated financial statements for stock options and warrants which are granted, modified or vested subsequent to April 1, 2006. As of March 31, 2006, all options and warrants were fully vested, and as such, adopting SFAS No. 123R on April 1, 2006, did not have an effect on the Company’s results of operations or financial position. The compensation expense recognized will include the estimated expense for stock options granted, based on the grant date fair value estimated in accordance with the provisions of SFAS No. 123R.

Concurrent with the Stock Split, effected on June 16, 2006, the Company modified the outstanding warrants, doubling the number of warrants and reducing the exercise price in half to reflect the Stock Split. Since the warrant terms did not contain an anti-dilution provision, during the six months ended September 30, 2006, the Company was required to record share-based compensation in the amount of $16,201,950, reflecting the change in the warrants’ fair value before and after the Stock Split. This non-cash charge was previously included as a separate component in operating expenses for the six months ended September 30, 2006 and has been included in general and administrative expenses for the current period presentation. The Company also recorded a deferred tax benefit of $1,058,034 as a result of the charge, which reduced income tax expense for the period. See Note I for further discussion of this tax benefit.

The fair value of the warrants at the date of the modification was estimated using a Black-Scholes option pricing model with the following weighted average assumptions:


Expected life (years)

 

 

4-7

 

Expected volatility

 

 

65

%

Risk-free interest rate

 

 

6

%

Dividend yield

 

 

0

%

On August 22, 2007, the Company granted, to various employees, options under the Employee Plans to acquire 102,850 shares of common stock at $3.30 per share, the closing price of the stock on August 21, 2007.  These options have a life of five years from the date of grant (or thirty days after termination for any reason), and vest 25% after each of the first two years, and 50% after the third year. The fair value of the options was determined to be $170,536, which will be expensed as share-based compensation over a three year period in accordance with the vesting period of the options.

The fair value of these options at the date of grant was estimated using a Black-Scholes option pricing model with the following weighted average assumptions.

Expected life (years)

 

 

3

 

Expected volatility

 

 

70

%

Risk-free interest rate

 

 

6

%

Dividend yield

 

 

0

%



21





A summary of stock option and warrant activity during the nine months ended December 31, 2007 follows:

 

 

Number of

Shares

 

Weighted

Average

Exercise

Price

 

Weighted

Average

Remaining

Contractual

Life

 

Aggregate

Intrinsic

Value

 

Outstanding as of March 31, 2007

 

 

2,994,000

 

$

1.14

 

 

4.10

 

$

13,302,145

 

Granted

 

 

417,850

 

 

4.28

 

 

4.75

 

 

 

Exercised

 

 

(2,075,000

)

 

1.13

 

 

3.82

 

 

6,187,860

 

Forfeited

 

 

 

 

 

 

 

 

 

Outstanding as of December 31, 2007

 

 

1,336,850

 

$

2.13

 

 

3.72

 

$

2,785,830

 

Exercisable as of December 31, 2007

 

 

994,000

 

$

1.42

 

 

2.56

 

$

2,703,550

 

Except for the 102,850 and 240,000 options granted during the nine months ended December 31, 2007, all options and warrants outstanding as of December 31, 2007 were fully vested. Prior to July 24, 2007, upon exercise of options and warrants, the Company issued previously authorized but unissued common stock to the holders. Commencing July 24, 2007, upon exercise the Company issued shares from treasury shares to the holders.  Of the 2,075,000 warrants exercised during the nine months ended December 31, 2007, 1,515,000 shares were issued from treasury shares. The difference between the original cost of the treasury shares ($4,126,067) and the proceeds received from the warrant holders ($1,744,102) was recorded as a reduction in retained earnings.

The intrinsic value of the warrants exercised during the nine months ended December 31, 2007 was approximately $6,188,000 and the tax benefit from the exercise of such warrants is expected to approximate $1,772,000 for income tax purposes. As of March 31, 2007, a deferred tax benefit of approximately $3,060,000 was provided on these warrants in connection with the share-based compensation charge discussed above. During the nine-month period ended December 31, 2007, the Company adjusted the deferred tax asset and reduced additional paid-in capital by $1,268,307 as a result of the exercise.

The following table summarizes information about the options and warrants outstanding at December 31, 2007, of which 994,000 are exercisable:

 

 

Options and Warrants Outstanding

 

Range of
Exercise Prices

 

Amount

 

Weighted Average
Exercise Price

 

Weighted Average
Remaining Contractual Life

 

Aggregate
Intrinsic
Value

 

$0.93

-

$1.22

 

 

899,000

 

$1.14

 

3.2

 

$

 2,657,550

 

 

 

$1.80

 

 

20,000

 

$1.80

 

5.2

 

 

46,000

 

 

 

$3.30

 

 

102,850

 

$3.30

 

4.7

 

 

82,280

 

 

 

$4.60

 

 

315,000

 

$4.60

 

4.7

 

 

 

 

 

 

 

 

1,336,850

 

$2.13

 

3.7

 

$

2,785,830

 

Included in general and administrative expenses for the three and nine-month periods ended December 31, 2007, is $210,867 of share-based compensation relating to the options issued in August and November 2007.

C.

Inventories

The components of inventories are as follows:

 

 

December 31,
2007

 

March 31,
2007

 

Finished products:

 

 

 

 

 

 

 

Fragrances

 

$

32,817,419

 

$

48,857,570

 

Watches

 

 

2,029,216

 

 

1,164,864

 

Handbags

 

 

379,473

 

 

31,359

 

Components and packaging material: 

 

 

 

 

 

 

 

Fragrances

 

 

16,830,755

 

 

20,352,274

 

Watches

 

 

29,204

 

 

24,241

 

Raw material

 

 

2,878,584

 

 

3,144,728

 

 

 

 

54,964,661

 

 

73,575,036

 

Less non-current portion

 

 

8,143,000

 

 

17,392,000

 

Current portion

 

$

46,821,661

 

$

56,183,036

 



22





The cost of inventories includes product costs and handling charges, including an allocation of the Company’s applicable overhead in the approximate amount of $4,694,000 and $4,333,000 at December 31, 2007 and March 31, 2007, respectively.

As is more fully described in Note J, one of the Company’s licensors, GUESS? Inc., filed a complaint against the Company alleging that GUESS? fragrance products were being sold in unauthorized retail channels. The Company subsequently entered into a settlement agreement with GUESS? that, among other things, requires pre-approval of each international customer to whom the Company sells GUESS? fragrances. The complaint was subsequently withdrawn.  If the Company were to be found in breach of its agreement with GUESS?, Inc. at any point in the future, termination or modification of the license agreement could occur.

As of December 31, 2007, our inventories of GUESS? products totaled approximately $18.8 million, of which approximately $6.3 million has been classified as non-current (approximately $30.8 million and $16.5 million, respectively, at March 31, 2007). If the licensing agreement were to be terminated or modified at any time in the future, the Company may be required to record charges to operations to reduce the recorded value of such inventories to the amounts which would be realized upon their sale or liquidation.

D.

Trademarks and Licenses

Trademarks and licenses are attributable to the following brands:

 

 

December 31,
2007

 

March 31,
2007

 

Estimated
Life
(in years)

XOXO

 

$

4,285,495

 

$

4,670,727

 

5

Fred Hayman Beverly Hills (“FHBH”)

 

 

2,820,361

 

 

2,820,361

 

10

Paris Hilton

 

 

674,103

 

 

468,691

 

5

Other

 

 

216,546

 

 

216,546

 

5-25

 

 

 

7,996,505

 

 

8,176,325

 

 

Less – accumulated amortization

 

 

(5,055,111

)

 

(4,263,542

)

 

 

 

$

2,941,394

 

$

3,912,783

 

 

During the year ended March 31, 2007, the Company recorded an impairment charge of $1,129,273 in connection with the XOXO license as the estimated future net cash flows for the remaining period of the license were determined to be less than the license’s carrying value.  During the nine-months ended December 31, 2007, the Company recorded an additional impairment charge of $385,232 in connection with this license.

E.

Borrowings

The composition of borrowings is as follows:

 

 

December 31,

2007

 

March 31,

2007

 

Revolving credit facility payable to GMAC Commercial Credit LLC, interest at LIBOR plus 2.75% or prime minus .25% (7.25% at December 31, 2007) at the Company’s option.

 

$

 

$

16,775,318

 

Capital leases payable to Provident Equipment Leasing, collateralized by certain equipment and leasehold improvements, payable in equal quarterly installments of $257,046, including interest, through July 2009.

 

 

1,683,825

 

 

2,342,069

 

Capital lease payable to IBM, collateralized by certain computer equipment, payable in equal monthly installments of $3,648, including interest, through
December 2009.

 

 

87,437

 

 

117,188

 

 

 

 

1,771,262

 

 

19,234,575

 

Less: long-term portion

 

 

797,942

 

 

1,536,959

 


Borrowings, current portion

 

$

973,320

 

$

17,697,616

 



23





On July 20, 2001, the Company entered into a Loan and Security Agreement (the “Loan Agreement”) with GMAC Commercial Credit LLC (“GMACCC”). On January 4, 2005, the Loan Agreement was extended through July 20, 2006. Under the Loan Agreement, the Company was able to borrow, depending on the availability of a borrowing base, on a revolving basis, up to $20,000,000 at an interest rate of LIBOR plus 2.75% or the Bank of New York’s prime rate, at the Company’s option.

On January 10, 2006, the Loan Agreement was amended, increasing the loan amount to $30,000,000 with an additional $5,000,000 available at the Company’s option. In addition, the maturity was extended through July 20, 2008, and the interest rate was reduced to 0.25% below the prime rate. During May 2006, the Company exercised its option and increased the line of credit to $35,000,000.

On September 13, 2006, the Loan Agreement was further amended, temporarily increasing the loan amount to $40,000,000 until December 13, 2006, at which time the maximum loan amount reverted back to $35,000,000.

At December 31, 2007, based on the borrowing base at that date, available borrowing under the credit line amounted to $29,319,000, of which there was no balance outstanding .  As of March 31, 2007, $16,775,318 was utilized. Restricted cash represents collections of trade accounts receivable deposited with our bank and pending transfer to GMACCC. As of December 31, 2007, the restricted cash balance was zero.  As of March 31, 2007, $1,273,896 was on deposit with our bank pending transfer.

Substantially all of the assets of the Company, excluding the New Jersey warehouse equipment discussed below, collateralize the credit line borrowing. The Loan Agreement contains customary events of default and covenants which prohibit, among other things, incurring additional indebtedness in excess of a specified amount, paying dividends, creating liens, and engaging in mergers and acquisitions without the prior consent of GMACCC. The Loan Agreement also contains certain financial covenants relating to net worth, interest coverage and other financial ratios.

Although the Company substantially exceeded the net worth covenant, it was not in compliance with the fixed charge covenant as of March 31, 2007. An amendment to the agreement was requested from the lender, which was granted on June 27, 2007, and which revised such covenant through March 31, 2008.

As of December 31, 2007 and September 30, 2007, we were not in compliance with our minimum EBITDA requirements.  We requested amendments of our agreement from our lender, which were granted on February 6, 2008 and November 9, 2007, respectively, and which revised such covenant at those dates. The Loan Agreement, as amended, also contains certain financial covenants relating to net worth, interest coverage and other financial ratios, which we were in compliance with as of December 31, 2007 and September 30, 2007.

On August 16, 2004, GMACCC approved a continuation of the Company’s common stock buyback program not to exceed $8,000,000. During December 2006, the Company effectively completed this program with approximately $198,000 remaining.

During May 2006, the Company entered into an agreement with Provident Equipment Leasing (“Provident”) covering approximately $2,761,000 of certain warehouse equipment and leasehold improvements to be purchased for the Company’s new leased distribution center in New Jersey. Provident advanced, on behalf of the Company, progress payments to various suppliers based on the work completed. In accordance with the terms of the agreement, the advances bore interest at a rate of 1% per month until all payments were made, at which time the arrangement converted to a thirty-six month lease, which has been classified as a capital lease. The Company has an option to purchase the equipment and leasehold improvements at the end of the lease term for $1.

On December 15, 2006, the Company entered into a lease agreement with International Business Machines (“IBM”) covering approximately $124,000 of computer equipment which has been classified as a capital lease. The Company has an option to purchase the computer equipment at the end of the lease term for $1.



24





F.

Related Party Transactions

Related party transactions include the following balances:

 

December 31,

2007

 

March 31,

2007

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Accounts receivable from related parties:

 

 

 

 

 

 

 

 

 

 

 

 

Perfumania

$

12,088,389

 

$

6,101,456

 

 

 

 

 

 

 

Other related parties

 

 

 

7,931,006

 

 

 

 

 

 

 

 

$

12,088,389

 

$

14,032,462

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended
December 31,

 

Nine Months Ended
December 31,

 

 

2007

 

2006

 

2007

 

2006

 

Sales from continuing operations to
related parties:

 

 

 

 

 

 

 

 

 

 

 

 

Perfumania

$

9,488,470

 

$

1,996,771

 

$

39,778,788

 

$

7,279,013

 

Other related parties

 

 

 

11,680,807

 

 

8,004,914

 

 

26,128,763

 

 

$

9,488,470

 

$

13,677,578

 

$

47,783,702

 

$

33,407,776

 

The Company had net sales from continuing operations of $39,778,788 and $7,279,013 during the nine-month periods ended December 31, 2007 and 2006 ($9,488,470 and $1,996,771 during the three months ended December 31, 2007 and 2006, respectively), respectively, to Perfumania, Inc. (“Perfumania”), a wholly-owned subsidiary of E Com Ventures, Inc. (“ECMV”). These amounts exclude sales of Perry Ellis brand products during the nine and three month periods ended December 31, 2006 in the amount of $5,512,469 and $958,370, respectively.

The Company’s former Chairman and Chief Executive Officer had an ownership interest and held identical management positions in ECMV until February 2004. Transactions with Perfumania have historically been presented as related party transactions.  ECMV’s current majority shareholders acquired an approximate 12.2% ownership interest in the Company during August and September 2006, and accordingly, transactions with Perfumania continue to be presented as related party transactions. Perfumania is one of the Company’s largest customers, and transactions with Perfumania are closely monitored by management, and any unusual trends or issues are brought to the attention of the Company’s Audit Committee and Board of Directors. Perfumania offers the Company the opportunity to sell its products in approximately 275 retail outlets and the Company’s pricing and terms with Perfumania take into consideration the relationship existing between the companies for over 15 years. Pricing and terms with Perfumania reflect (a) the volume of Perfumania’s purchases, (b) a policy of no returns from Perfumania, (c) minimal spending for advertising and promotion, (d) exposure of the Company’s products provided in Perfumania’s store windows and (e) minimal distribution costs to fulfill Perfumania orders shipped directly to their distribution center.

The Company owned 378,101 shares of ECMV common stock, which was previously classified as an available-for-sale security. The Company’s adjusted cost basis for the shares was $1,648,523 or $4.36 per share. During August and September 2006, the Company sold all of the shares in the open market for $3,423,147. Accordingly, the Company recorded a gain on sale of $1,774,624 in the accompanying condensed consolidated statements of operations for the nine-month period ended December 31, 2006 (See Note I for discussion of the income tax effect of the sale).

While the Company’s invoice terms to Perfumania are stated as net ninety days, for over ten years, management has granted longer payment terms, taking into consideration the factors discussed above. Management evaluates the credit risk involved, considering Perfumania’s reported results and comparable store sales performance. Management monitors the account activity to ensure compliance with its limits. Net trade accounts receivable owed by Perfumania to the Company totaled $12,088,389 and $6,101,456 at December 31, 2007 and March 31, 2007, respectively.

Prior to July 1, 2007, sales to parties related to the Company’s former Chairman and CEO were treated as related party sales. As of June 30, 2007, the former Chairman and CEO’s beneficial ownership interest in the Company had declined to approximately 7.6%, further declining during the quarter ended September 30, 2007, to less than 5% (less than 2% at December 31, 2007).



25





Accordingly, effective July 1, 2007, transactions with parties related to the former Chairman and CEO are no longer included as related party activity. Net sales to these parties and reported as related party sales during the three months ended December 31, 2007 and 2006 were $0 and $11,680,807, respectively. Net sales to these parties during the nine months ended December 31, 2007 and 2006 were $8,004,914 and $26,128,763 respectively. The above amounts exclude sales of the discontinued Perry Ellis product during the three and nine months ended December 31, 2006 of $5,936,742 and $15,027,792, respectively.

As of March 31, 2007 trade receivables from related parties included $7,931,006 from these customers, which were current in accordance with their sixty or ninety day terms. The Company also reimbursed these related party distributors for advertising and promotional expenses totaling approximately $77,000 and $1,801,000 for the nine months ended December 31, 2007 and 2006, ($0 and $734,000 during the three months ended December 31, 2007 and 2006) respectively.

During the nine months ended December 31, 2006, the Company purchased $1,160,420 ($386,807 during the three months ended December 31, 2006) in television advertising on the “Adrenalina” show, which is broadcast in various U.S. markets and Latin American countries. The Company’s former Chairman and CEO has a controlling ownership interest in a company, which has the production rights to the show and publishes certain magazines. During the nine months ended December 31, 2006, the Company also purchased $21,875 ($4,075 during the three months ended December 31, 2006) of advertising space in these magazines. There were no such transactions during the three or nine months ended December 31, 2007.

G.

Basic and Diluted Earnings Per Common Share

The following is the reconciliation of the numerators and denominators of the basic and diluted net income per common share calculations, retroactively restated for the Stock Split:

 

 

Three Months Ended
December 31,

 

 

 

2007

 

2006

 

Income (loss) from continuing operations

 

$

178,962

 

$

(5,463,157

)

Income from discontinued operations

 

 

3,719

 

 

23,402,021

 

Net income

 

$

182,681

 

$

17,938.864

 

Weighted average number of shares issued

 

 

29,977,289

 

 

28,945,550

 

Weighted average number of treasury shares

 

 

(10,042,703

)

 

(10,674,805

)

Weighted average number of shares outstanding used in basic earnings per share calculation

 

 

19,934,586

 

 

18,270,745

 

Basic net  income (loss) per common share – continuing operations

 

$

0.01

 

$

(0.30

)

Basic net income per common share – discontinued operations

 

$

0.00

 

$

1.28

 

Weighted average number of shares outstanding used in basic earnings per share calculation

 

 


19,934,586

 

 

18,270,745

 

Effect of dilutive securities:

 

 

 

 

 

 

 

Stock options and warrants

 

 

819,778

 

 

 

Weighted average number of shares outstanding used in diluted earnings per share calculation

 

 

20,754,364

 

 

18,270,745

 

Diluted net income (loss) per common share – continuing operations(1)

 

$

0.01

 

$

(0.30

)

Diluted net income per common share – discontinued operations(1)

 

$

0.00

 

$

1.28

 

Antidilutive securities not included in diluted earnings per share calculation:

 

 

 

 

 

 

 

Options and warrants to purchase common stock

 

 

417,850

 

 

2,494,000

 

Exercise Price

 

 

$3.30-$4.60

 

 

$0.93-$1.80

 



26






 

 

Nine Months Ended
December 31,

 

 

 

2007

 

2006

 

Income  (loss) from continuing operations

 

$

2,091,201

 

$

(22,233,088

)

Income from discontinued operations

 

 

25,350

 

 

29,700,305

 

Net income

 

$

2,116,551

 

$

7,467,217

 

Weighted average number of shares issued

 

 

29,801,689

 

 

28,736,860

 

Weighted average number of treasury shares

 

 

(10,771,850

)

 

(10,601,706

)

Weighted average number of shares outstanding used in basic and fully diluted earnings per share calculation

 

 

19,029,839

 

 

18,135,154

 

Basic net income (loss) per common share – continuing operations(1)

 

$

0.11

 

$

(1.23

)

Basic net income per common share – discontinued operations(1)

 

$

0.00

 

$

1.64

 

Weighted average number of shares outstanding used in basic earnings per share calculation

 

 


19,029,839

 

 

18,135,154

 

Effect of dilutive securities:

 

 

 

 

 

 

 

Stock options and warrants

 

 

1,502,774

 

 

 

Weighted average number of shares outstanding used in diluted earnings per share calculation(1)

 

 

20,532,613

 

 

18,135,154

 

Diluted net income (loss) per common share – continuing operations(1)

 

$

0.10

 

$

(1.23

)

Diluted net income per common share – discontinued operations(1)

 

$

0.00

 

$

1.64

 

Antidilutive securities not included in diluted earnings per share calculation:

 

 

 

 

 

 

Options and warrants to purchase common stock

 

 

417,850

 

 

2,494,000

Exercise Price

 

 

$3.30-$4.60

 

 

$0.93-$1.80

———————

(1)

In accordance with paragraph 15 of Statement of Financial Accounting Standards (“SFAS”) No. 128, “ Earnings Per Share” , the number of shares utilized in the calculation of diluted (loss) earnings per share from continuing operations, discontinued operations and net income were the same as those used in the basic calculation of earnings per share for the three and nine months ended December 31, 2006, as we incurred a loss from continuing operations for those periods.

H.

Cash Flow Information

The Company considers temporary investments with an original maturity of three months or less to be cash equivalents. Supplemental disclosures of cash flow information are as follows:

 

 

Nine Months Ended
December 31,

 

 

 

2007

 

2006

 

Cash paid for: 

 

 

 

 

 

 

 

Interest

 

$

1,274,274

 

$

2,231,902

 

Income taxes

 

$

854,420

 

$

2,634,259

 

Supplemental disclosures of non-cash investing and financing activities are as follows:

Nine months ended December 31, 2006:

·

The consideration received from the sale of the Perry Ellis fragrance brand and assets related thereto, included an accounts receivable of $5,035,694, pending final inventory valuations.

·

Change in unrealized holding gain of $4,342,338 on the investment in affiliate, net of deferred taxes.



27





I.

Income Taxes for Continuing Operations

The tax provision for continuing operations for the three-month periods ended December 31, 2007 and 2006 and the nine-month period ended December 31, 2007 reflect an estimated effective rate of 38%.

The tax provision for the nine-month period ended December 31, 2006 was affected by:

(1)

a limitation on the estimated tax benefit that is expected to result from the share-based compensation charge related to the warrant modification. Such benefit will be limited by the maximum allowable annual compensation deduction for corporate officers under Section 162 (m) of the Internal Revenue Code. Consequently, the benefit recorded in the prior year period reflected management’s best estimate at that time based upon assumptions regarding the timing and market value of the Company’s common stock upon exercise of the warrants and the amount and nature of other forms of compensation to be paid to the holders of the warrants using the method in which the cash compensation (salary and bonus) of the related individuals takes priority over the share-based compensation in determining the annual limitation. Actual tax benefits realized may be greater or less than the amounts recorded, and such differences may be material. The Company will adjust this deferred tax asset as additional information becomes available, with adjustments reflected in the Company’s income tax (benefit) provision for the period in which the adjustments are identified. As of March 31, 2007, the Company adjusted the deferred tax asset due to a change in the maximum allowable annual compensation deduction for corporate officers under Section 162 (m), as a result of the resignation of the Company’s former Chairman and CEO, in February 2007.  

(2)

the difference in basis of the ECMV shares sold during the current period as such sale resulted in a capital loss of $1,083,823 for income tax purposes, for which we are able to offset with capital gains, as well as a portion of the gain in connection with the December 2006 Perry Ellis fragrance brand (See Notes M and O, respectively, for further discussion). The Company had previously recorded a non-cash charge of $2,858,447 during fiscal 2002, reducing the basis of the shares for financial reporting purposes.  

On April 1, 2007, the Company adopted the provisions of Financial Accounting Standards Board (“FASB”) Interpretation 48 (“FIN 48”) Accounting for Income Tax Uncertainties , which clarifies the accounting for uncertainty in income taxes recognized in the financial statements in accordance with SFAS Statement No. 109 Accounting for Income Taxe s. FIN 48 prescribes a recognition threshold of more-likely-than-not and a measurement attribute on all tax positions taken or expected to be taken in a tax return in order to be recognized in the financial statements. In making this assessment, a company must determine whether it is more-likely-than-not that a tax position will be sustained upon examination, including resolution of any related appeals or litigation processes, based solely on the technical merits of the position and must assume that the tax position will be examined by appropriate taxing authority that would have full knowledge of all relevant information. Once the recognition threshold is met, the tax position is then measured to determine the actual amount of benefit to recognize in the financial statements. In addition, the recognition threshold of more-likely-than-not must continue to be met in each reporting period to support continued recognition of the tax benefit. Tax positions that previously failed to meet the more-likely-than-not recognition threshold should be recognized in the first financial reporting period in which that threshold is met. Previously recognized tax positions that no longer meet the more-likely-than-not recognition threshold should be derecognized in the financial reporting period in which that threshold is no longer met. As a result of the implementation of FIN 48, the Company did not recognize a liability for unrecognized tax benefits and, accordingly, was not required to record any cumulative effect adjustment to beginning of year retained earnings. As of both the date of adoption and December 31, 2007, there was no material liability for income tax associated with unrecognized tax benefits. The Company does not anticipate any material adjustments relating to unrecognized tax benefits within the next twelve months, however, the outcome of tax matters is uncertain and unforeseen results can occur.

J.

License and Distribution Agreements

During the year ended March 31, 2007, the Company held exclusive worldwide licenses to manufacture and sell fragrance and other related products for Paris Hilton, GUESS?, Ocean Pacific (“OP”), Maria Sharapova, Andy Roddick, babyGund, Perry Ellis and XOXO. During December 2006, the Company sold its Perry Ellis licensing rights and other related assets to Perry Ellis International, its Licensor. See Note O for further discussion.



28





Under all of the existing license agreements, we must pay a minimum royalty, whether or not any product sales are made, and spend minimum amounts for advertising based on sales volume. Except as discussed below, the Company believes it is presently in compliance with all material obligations under these agreements.

GUESS?, Inc. (“GUESS?”) filed a complaint against the Company alleging that GUESS? fragrance products were being sold in unauthorized retail channels. Although the Company did not sell such products directly to these channels, it represented a violation of the Company’s license agreement with GUESS?. On May 7, 2007, the Company entered into a settlement agreement with GUESS? which, among other items, requires GUESS?’s reapproval of all international distributors selling GUESS? fragrance products, payment of liquidated damages in the amount of $500,000, in nine equal monthly installments of $55,556, (which was expensed in the year ended March 31, 2007), as well as strict monitoring of distribution channels. The complaint was subsequently withdrawn.  Any further violations surrounding unapproved distribution could result in termination of the license agreement. During the quarter ended March 31, 2007, the Company stopped shipments to international distributors. Over the last six months GUESS? has approved certain international distributors and the Company has commenced shipments to these approved distributors. The Company continues to submit approval requests for additional international distributors in accordance with procedures outlined in the license agreement.

On June 21, 2007, the Company entered into an exclusive license agreement with VCJS, LLC, to develop, manufacture and distribute prestige fragrances and related products under the Jessica Simpson name. The initial term of the agreement expires five years from the date of the first product sales and is renewable for an additional five years if certain sales levels are met. The Company must pay a minimum royalty to VCJS, LLC, whether or not any product sales are made, and spend minimum amounts for advertising based upon sales volume. The Company anticipates that the first fragrance under this agreement will be launched during fall 2008.

On August 1, 2007, the Company entered into an exclusive license agreement with Kobra International, Ltd., to develop, manufacture and distribute prestige fragrances and related products under the Nicole Miller name. The initial term of the agreement expires on September 30, 2013 and is renewable for two additional terms of three years each, if certain sales levels are met. The Company must pay a minimum royalty, whether or not any product sales are made, and spend minimum amounts for advertising based upon sales volume. The Company anticipates launching a new fragrance under this license in the fall of 2008, and has recently resumed the manufacturing of certain previously developed Nicole Miller fragrances.

K.

Segment Information

In accordance with SFAS No. 131, " Disclosures about Segments of an Enterprise and Related Information ", the Company determined its operating segments on the same basis that it uses to evaluate performance internally.

Prior to the quarter ended December 31, 2005, the Company operated in one industry segment as a manufacturer and distributor of prestige fragrances and beauty related products. During December 2005 and March 2006, the Company commenced sales of watches and handbags, respectively, both of which are under license agreements with Paris Hilton Entertainment, Inc. Revenues from the sale of watches and handbags during the nine- month period ended December 31, 2007 totaled $3,074,741 and $307,111, respectively ($736,142 and $1,285,604 for the nine months ended December 31, 2006, respectively). Included in inventories at December 31, 2007, is  $2,058,420 and $379,473 relating to watches and handbags, respectively ($1,189,105 and $31,359 for watches and handbags at March 31, 2007). The Company anticipates preparing full segment disclosure if these operations become more significant.

L.

L egal Proceedings

On June 21, 2006, the Company was served with a stockholder derivative action (the “Derivative Action”) filed in the Circuit Court of the Seventeenth Judicial Circuit in and for Broward County, Florida by NECA-IBEW Pension Fund, purporting to act derivatively on behalf of the Company.

The Derivative Action named Parlux Fragrances, Inc. as a defendant, along with Ilia Lekach, Frank A. Buttacavoli, Glenn Gopman, Esther Egozi Choukroun, David Stone, Jaya Kader Zebede and Isaac Lekach, each of whom was a director of the Company at that date. The Derivative Action related to the proposal (previously disclosed in the Company’s June 14, 2006 Form 8-K) from PF Acquisition of Florida LLC (“PFA”), which was



29





owned by Ilia Lekach, to acquire all of the outstanding shares of common stock of the Company for $29.00 ($14.50 after the Stock Split) per share in cash (the “Proposal”).

The Derivative Action seeks to remedy the alleged breaches of fiduciary duties, waste of corporate assets, and other violations of law and seeks injunctive relief from the Court appointing a receiver or other truly neutral third party to conduct and/or oversee any negotiations regarding the terms of the Proposal, or any alternative transaction, on behalf of the Company and its public shareholders, and to report to the Court and plaintiff’s counsel regarding the same. The Derivative Action alleges that the unlawful plan to attempt to buy out the public shareholders of the Company without having proper financing in place, and for inadequate consideration, violates applicable law by directly breaching and/or aiding the other defendants’ breaches of their fiduciary duties of loyalty, candor, due care, independence, good faith and fair dealing, causing the complete waste of corporate assets, and constituting an abuse of control by the defendants. Before any response to the original complaint was due, counsel for plaintiffs indicated that an amended complaint would be filed. That First Amended Complaint (the "Amended Complaint") was served on Company counsel on August 17, 2006.

The Amended Complaint continues to name the then Board of Directors as defendants along with the Company, as a nominal defendant. The Amended Complaint is largely a collection of claims previously asserted in a 2003 derivative action, which the plaintiffs in that action, when provided with additional information, elected not to pursue. It adds to those claims, assertions regarding a 2003 buy-out effort and the abandoned buy-out effort of PF Acquisition of Florida. It also contains allegations regarding the prospect that the Company's stock might be delisted because of a delay in meeting SEC filing requirements. It relies in large measure on a bevy of media articles rather than facts known to the plaintiffs.

The Company and the other defendants engaged Florida securities counsel, including the counsel who successfully represented the Company in the previous failed derivative action, and on September 18, 2006, moved to dismiss the Amended Complaint. A Second Amended Complaint was filed on October 26, 2006, adding alleged violations of securities laws, which the Company moved to dismiss of December 1, 2006. A hearing on the dismissal was held on March 8, 2007. On March 22, 2007, the motion to dismiss was denied and the defendants were provided twenty days to respond, and a response was filed on March 29, 2007. Since that time there has been extremely limited discovery conducted in the case. Some documents have been produced. Narrow interrogatories were answered. There have been no depositions and none has even been scheduled. A number of the factual allegations upon which the various complaints were based have fallen away, simply by operation of time. Based on the allegations in the Second Amended Complaint, upon the information collected in the earlier litigation and upon the information provided in response to the limited discovery noted above, it is believed that the Second Amended complaint is without merit.

On March 2, 2007, the Company, Ilia Lekach and Frank Buttacavoli were named as defendants, along with Perry Ellis International, Inc. and its Chairman and CEO, George Feldenkreis, Rene Garcia, Quality King Distributors, Inc., E Com Ventures, Perfumania, Model Reorg, Inc., Glenn Nussdorf, DFA Holdings, Inc., Duty Free Americas, Inc. Falic Fashion Group, LLC, Simon Falic and Jerome Falic. This action by Plaintiff Victory International (“Victory”) relates to Perry Ellis International’s failure to consent to the assignment by the Company of its contractual license to the Perry Ellis brand of perfumes. The Plaintiff is alleging that Perry Ellis International unreasonably withheld its consent and, instead, conspired with a variety of people to prevent Victory from obtaining this license. No direct allegations are made against the Company. The allegations against Messrs. Lekach and Buttacavoli relate to the recent attempt by Glenn Nussdorf to replace all of the directors of the Company with his nominees. The First Amended Complaint alleges that Mr. Nussdorf and certain affiliates are among the alleged co-conspirators with Perry Ellis International to prevent Victory from obtaining the license. On May 18, 2007, the Company, along with Messrs Lekach and Buttacavoli, filed a motion to dismiss on the basis that the complaint failed to state a cause of action against any of them. All other defendants moved to dismiss as well, on a host of different theories. At the same time we moved to transfer the case from the District of New Jersey to the Southern District of Florida, a motion in which 14 of the 17 defendants joined. After a hearing in December, the District Court in New Jersey granted the motion to transfer on January 2, 2008, and ordered the case transferred to the Southern District of Florida. The motions to dismiss are traveling with the case as is the customary practice. It is expected that the Florida Court will rule on those pending motions sometime in the last Spring or early Summer. There has been no discovery conducted. Plaintiff’s request for preliminary discovery to address jurisdictional issues was denied by the Court. Based on very preliminary analysis, since there has been no discovery to date, it appears that the Company and the individual defendants have meritorious defenses to all of the claims asserted.




30





Management believes that the ultimate outcome of these matters will not have a material effect on the Company’s financial position or results of operations.

M.

Facility Acquisition and Sale

On July 22, 2005, the Company finalized an agreement with SGII, Ltd. (an unrelated Florida limited partnership), to purchase certain real property in Sunrise, Florida for approximately $14 million. The property, which was intended to be used as the Company’s corporate headquarters and main distribution center, includes approximately 15 acres of land and a 150,000 square foot distribution center, with existing office space of 15,000 square feet. On December 29, 2005, the Company closed on the Sunrise Facility, financing $12.75 million of the purchase price under a fifteen year conventional mortgage with GE Commercial Finance Business Property Corporation.

As a result of various factors including the Company’s continuing growth, the increase in trucking costs resulting primarily from the increase in fuel prices and South Florida’s susceptibility to major storms, management and the Company’s Board of Directors determined that it would be more cost effective and prudent to relocate a major part of the Company’s warehousing and distribution activities to the New Jersey area, close to where the Company’s products are filled and packaged. Accordingly, on April 17, 2006, the Company entered into a five-year lease for 198,500 square feet of warehouse space in New Jersey, to also serve as a backup information technology site if the current Fort Lauderdale, Florida location encounters unplanned disruptions. The Company commenced activities in the New Jersey facility during the latter part of August 2006.

On May 15, 2006, the Company entered into an agreement to sell the Sunrise Facility for $15 million receiving a non-refundable deposit of $250,000 from the buyer. The sale was completed on June 21, 2006, and the mortgage was repaid. The Company has recorded a gain of $494,465 from the sale, which is included in the accompanying condensed consolidated statement of operations for the nine months ended December 31, 2006.

N.

New Accounting Pronouncements

In September 2006, the FASB issued Statement of Financial Accounting Standards (“SFAS”) No. 157, Fair Value Measurements ” (“SFAS No. 157”). SFAS No. 157 defines fair value, establishes a framework for measuring fair value and enhances disclosures about fair value measures required under other accounting pronouncements, but does not change existing guidance as to whether or not an instrument is carried at fair value. SFAS No. 157 is effective for fiscal years beginning after November 15, 2007. The Company is currently reviewing the provisions of SFAS No. 157 to determine the impact, if any, on its condensed consolidated financial statements.

In February 2007, the FASB issued SFAS No. 159, “ The Fair Value Option for Financial Assets and Financial Liabilities - Including an Amendment of FASB No. 115 ” ("SFAS No. 159"). SFAS No. 159 permits companies to choose to measure many financial instruments and certain other items at fair value in order to mitigate volatility in reported earnings caused by measuring related assets and liabilities differently without having to apply complex hedge accounting provisions. SFAS No. 159 is effective for the Company's fiscal year ending March 31, 2009. The Company is currently assessing the impact of this statement on its condensed consolidated financial statements.

In December 2007, the FASB issued SFAS No. 141(R), Business Combinations (“ SFAS 141(R)”). SFAS 141(R) establishes principles and requirements for how the acquirer of a business recognizes and measures in its financial statements the identifiable assets acquired, the liabilities assumed, and any noncontrolling interest in the acquiree. SFAS 141(R) also provides guidance for recognizing and measuring the goodwill acquired in the business combination and determines what information to disclose to enable users of the financial statements to evaluate the nature and financial effects of the business combination. The provisions of SFAS 141(R) are effective for financial statements issued for fiscal years beginning after December 15, 2008. We are currently assessing the financial impact of SFAS 141(R) on our consolidated financial statements.

 

In December 2007, the FASB issued SFAS 160, Noncontrolling Interests in Consolidated Financial Statements — An Amendment of ARB No. 51 (“SFAS 160”). SFAS 160 amends Accounting Research Bulletin No. 51, “Consolidated Financial Statements,” or ARB 51, to establish accounting and reporting standards for the noncontrolling interest in a subsidiary and for the deconsolidation of a subsidiary. This statement also amends certain of ARB 51’s consolidation procedures for consistency with the requirements of SFAS 141(R). In addition, SFAS 160 also includes expanded disclosure requirements regarding the interests of the parent and its



31





noncontrolling interest. The provisions of SFAS 160 are effective for fiscal years beginning after December 15, 2008. Earlier adoption is prohibited. We are currently assessing the financial impact of SFAS 160 on our consolidated financial statements.

O.

Discontinued Operations

On November 28, 2006, the Company’s Board of Directors approved the sale of the Perry Ellis fragrance brand license back to Perry Ellis International (“PEI”) at a price of approximately $63 million, including approximately $21 million for inventory and promotional products relating to the brand. A definitive agreement was signed on December 6, 2006 and the closing took place shortly thereafter. The sale included all inventory, promotional products, molds and other intangibles. The transaction generated proceeds of approximately $63 million, and resulted in a pre-tax gain of approximately $34.3 million.

Beginning with the quarter ended December 31, 2006, the Perry Ellis brand activity has been presented as discontinued operations. Prior period statements of operations have been retrospectively adjusted. The activity for this discontinued operation is summarized as follows:

 

Three Months Ended

December 31,

 

 

Nine Months Ended

December 31,

 

 

2007

 

2006

 

 

2007

 

2006

 

Net revenues

$

5,999

 

$

11,701,541

 

 

$

40,887

 

$

35,992,631

 

Gain on sale of brand

 

 

$

34,277,316

 

 

 

 

$

34,277,316

 

Operating income

$

5,999

 

$

37,745,195

 

 

$

40,887

 

$

47,903,718

 

Income from discontinued operations

$

3,719

 

$

23,402,021

 

 

$

25,350

 

$

29,700,305

 


* * * *



32





SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

PARLUX FRAGRANCES, INC.

 

 

 

/s/ N EIL J. K ATZ

 

Neil J. Katz, Chairman and Chief Executive Officer

(Principal Executive Officer)

 

 

 

 

/s/ R AYMOND J. B ALSYS

 

Raymond J. Balsys, Chief Financial Officer

(Principal Financial and Principal Accounting Officer)

 

 

Date: February 7, 2008



33






Exhibit Index

Exhibit #

 

Description

10.2

 

The Parlux Fragrances, Inc. 2007 Stock Incentive Plan (incorporated by reference to Exhibit 10.2 to the Company’s registration on Form S-8, filed on December 28, 2007.)

10.86

 

Office Sublease Agreement, dated as of November 30, 2007, between the Company and Tarragon South Development Corp.

31.1

 

Certification of Chief Executive Officer Pursuant to §302 of the Sarbanes-Oxley Act of 2002.

31.2

 

Certification of Chief Financial Officer Pursuant to §302 of the Sarbanes-Oxley Act of 2002.

32.1

 

Certification of Chief Executive Officer Pursuant to §906 of the Sarbanes-Oxley Act of 2002.

32.2

 

Certification of Chief Financial Officer Pursuant to §906 of the Sarbanes-Oxley Act of 2002.





34


Grafico Azioni Parlux Fragrances, Inc. (MM) (NASDAQ:PARL)
Storico
Da Giu 2024 a Lug 2024 Clicca qui per i Grafici di Parlux Fragrances, Inc. (MM)
Grafico Azioni Parlux Fragrances, Inc. (MM) (NASDAQ:PARL)
Storico
Da Lug 2023 a Lug 2024 Clicca qui per i Grafici di Parlux Fragrances, Inc. (MM)